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ABSTRACT OF THE DISSERTATION
Role of VimA in Cell Surface Biogenesis in Porphyromonas gingivalis
by
Devon Otani Osbourne
Doctor of Philosophy, Graduate Program in Microbiology and Molecular Genetics
Loma Linda University, June 2011
Dr. Hansel M. Fletcher, Chairperson
Porphyromonas gingivalis is an important etiological agent of periodontal disease
- a disease that affects an estimated 49,000,000 people in the United States of America.
Periodontal disease includes gingivitis – inflammation of the gums, and periodontitis –
destruction of the teeth and their supporting tissues. Porphyromonas gingivalis is
associated with the chronic form of periodontal disease in addition to several systemic
diseases.
The vimA gene of P. gingivalis has been previously shown to play a significant
role in the biogenesis of gingipains (trypsin-like cysteine proteases). The vimA has also
been demonstrated to play a role in hemolysis, hemagglutination, autoaggregation, posttranslational protein modification, and LPS biogenesis. Though significant progress has
been made in characterizing this gene, much remained unsolved prior to this work,
especially as it relates to the molecular mechanisms and interactions of this protein in
surface biogenesis, transport and membrane integrity. The focus of our work was to
clarify the role of VimA on cell surface biogenesis. We were able to show via TEM and
AFM that there were significant differences between the vimA-defective mutant (FLL92)
and the wild-type (W83). Particularly, the topography of FLL92 showed numerous fine
structures compared with W83, and had an irregular, loosely bound capsule. Fimbrial
synthesis was also affected by the VimA mutation. FimA coupled immunogold particles
localized with the abundant fimbrial appendages in FLL92, compared with only a few

xvi

adhering in W83. Lectins were used to clarify the effect of the vimA mutation on the
glycosylation of outer-membrane proteins. Outer membrane proteins glycosylated with
Galactose (β 1,3) N-Acetylgalactosamine, N-acetyl-α-D-galactosamine, Galactose (β
1,4) N-Acetylglucosamine, N-acetyl-D-galactosamine and Sialic Acid (N-Acetyl neuramic
acid) were affected by the vimA mutation. Mass Spectrometric analysis of outermembrane and extracellular proteins identified several proteins in FLL92 that were
aberrantly expressed, missing and of varying abundance. In-silico analysis of VimA
predicted a likely role as an acyl transferase, with structural similarities to the FemABX
family of proteins – these proteins are involved in peptidoglycans synthesis. The
expression profile of lipid modified 3H labeled outer membrane proteins from FLL92
when compared with W83 was unchanged; however, a 27 kDa protein was observed in
the extracellular fraction of FLL92 that was twice as abundant in FLL92 as in W83.
Peptidoglycans isolated from FLL92 were shown to be dissimilar from those isolated
from W83 via TEM and AFM, with a slower rate of hydrolysis when exposed to
peptidoglycan specific hydrolytic enzymes. Taken together, we provide evidence that the
VimA in an important regulator of membrane biogeneis, and is a putative lipid
transferase.

xvii

CHAPTER ONE
INTRODUCTION

Periodontal Disease
Periodontal disease is the major cause of tooth loss in U.S. adults. Over 50% of
all American adults have gingivitis on an average of 3 to 4 teeth (107). This disease
affects the periodontum - the supporting tissue surrounding the tooth (periodontal
ligament, gingiva, and the alveolar bone). The disease results from the interaction of
heterogeneous etiological factors; including social and behavioral modulations, genetic
or epigenetic traits of the host, and formation of a complex subgingival biofilm (53).
Periodontal disease is initiated by the accumulation of microbial plaque in the gingival
crevice region; this plaque induces an inflammatory response – gingivitis (mild and
reversible inflammation of the gingiva – gum). In certain individuals, this condition may
progress to a chronic destructive inflammatory stage - periodontitis. This results from a
complex microbial infection which leads to tissue destruction, resulting from the
perturbation of the homeostasis between the host defenses and the subgingival
microbiota (119). The categories of periodontal disease include: gingivitis, chronic
periodontitis (or adult periodontitis), general juvenile periodontitis, aggressive
periodontitis, disease related periodontitis, and acute necrotizing periodontitis (6).
Periodontitis is irreversible, as it destroys bone and other tooth supporting structures.

Risk Factors for Periodontitis
The risk factors for periodontal disease include: smoking, hormonal changes in
girls/women –makes gums more sensitive and thus increases susceptibility to gingivitis,
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diabetes – 30% of all diabetics are estimated to have some form of periodontal disease,
genetic predisposition – 30 % of the population are 6 times more likely than the rest of
the population to develop the disease (74); medications – some drugs lessen salivary
flow thus affecting oral health, poor nutrition, stress, and systemic diseases. Periodontal
diseases have also been implicated in the increased risk of heart attack, increased risk
of preterm delivery and low weight babies, and increased difficulty in controlling blood
sugar levels in people with diabetes (29).

Bacterial Etiology of Periodontal Disease
The bacterial etiology of periodontal disease is rather complex and a variety of
organisms have been implicated in the initiation and progression of the disease. The
prevailing view, as supported by the literature, indicates that a number of these diseasecausing microbes are part of the normal flora of a healthy mouth, existing in commensal
harmony with the host amongst the 350 different bacterial species that are resident in
the subgingival niche. A disease episode ensues once there is a shift in the ecological
balance, due to the alteration in the absolute or relative number of certain organisms,
changes in pathological potential or modulation of particular host factors (Fig. 1.1).
The progression of adult periodontal disease was initially thought of as a broad
group of infections with multiple bacterial etiologies; recent evidence however has
suggested a primary pathogen: Porphyromonas gingivalis. This organism may act either
alone or in tandem with other putative periodontal pathogens including: Actinobacillus
actinomycetemcomitans, Fusobacterium nucleatum, Bacteroides forsythus,
Campylobater rectus, Prevotella intermedia, Treponema denticola, Treponema
pectinovorum, Selenomonas sputigenam, and Eikenella as part of a mixed infection; and
possibly in concert with the absence of beneficial species or the immunological
deficiencies of the host (44,57,82).
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In response to the bacteria accumulating on the teeth, the host mounts an
inflammatory response in the gingival tissue, which seeks to remove bacterial products
such as LPS and proteases that have penetrated the tissue. This inflammatory response
can also activate matrix metalloproteases - agents of collagen loss in tissues. Elevated
levels of interstitial collagenase often arise owing to the conversion of latent
collagenolytic enzymes into their active form by proteases and reactive oxygen species.
(83-85).
Commensal oral Streptococci are the principal early/initial colonizers of the
salivary pellicle on the coronal tooth surface. Subsequent colonization of additional
Gram positive along with Gram-negative bacteria occurs only as these initial colonizers
are established. As subgingival plaque develops due to the extension of the biofilm
below the gum line, the colonization of more pathogenic Gram-negative bacteria such as
P. gingivalis is manifested, and marks a further stage in the disease maturation
(79,130,154).

Virulence Factors
A variety of bacterial cell surface components including: capsule,
polysaccharides, proteases (gingipains), hemmaglutinin, lipopolysacharides, major outer
membrane proteins and fimbriae contribute to the virulence of Porphyromonas gingivalis
(82,155). This organism forms black-pigmented colonies on blood agar plates – due to
accumulation of -oxo heme dimer on the cell surface (120), is Gram-negative,
asaccharolytic anaerobe, which is an important etiologic agent of periodontal disease,
and is also associated with other systemic illnesses including cardiovascular disease
(28,31,43,98).
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Fimbriae
The fimbriae of P. gingivalis consists of a 41-49 kDa and 67-75 kDa cell surface protein
(depending on the strain) (34,47,49,156). These proteins constitute two distinct sets of
adhesins/receptors, and are recognized as critical virulence factors which influence the
initiation and progression of the disease (50). They cooperatively mediate adherence of
P. gingivalis to oral epithelial cells (61,132,138), salivary components - such as prolinerich proteins and statherin (5,8,94) and co-aggregation with other bacterial cells (4). The
major (long) fimbriae are filamentous components on the cell surface. Fimbrillin (FimA) is
the major subunit protein and mediates bacterial adhesion and colonization in targeted
sites. Sequence diversity of the fimA gene has been used to classify fimbriae into six
genotypes (I-V and Ib). The majority of periodontal patients carry P. gingivalis with type II
fimA organisms; these are associated with the more severe forms of periodontitis
followed by type IV. In healthy adults, the most prevalent fimA type of P. gingivalis is
type I. When type II FimA was substituted for type I FimA in the mouse periodontitis
model, there was increased phagocytosis by macrophages, suggesting that type II
macrophages interact more efficiently with macrophage phagocytic receptors than type I
fimbriae (148). The biofilm of Type II FimA also differs from those associated with type I,
i.e. are more luxuriant and are filled with widely clumped and tall colonies compared with
type I FimA (78).

Immune Response to FimA
Human peripheral macrophages and neutrophils have been shown to be induced to
overproduce several proinflammatory cytokines such as tumor necrosis factor,
interleukin 1 and interleukin 6 by fimbriae (104). T-cell activation can also be induced by
fimbriae in mice (60). Major fimbriae is also required for initial entry of P. gingivalis into
osteoblasts (157).
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Fig 1.1. Stages in the formation of dental plaque. Colonization of tooth surfaces
is initiated by bacterial adhesion to the salivary pellicle. Coaggregation and
coadhesion facilitate the development of multispecies communities. The
exchange of chemicals between neighboring bacteria promotes co-operation or
competition. In some cases, communication does not occur until a critical
biomass is reached. Adherent bacteria produce a matrix of complex
carbohydrates and/or extracellular nucleic acids, which helps to bind the biofilm
together and to protect the encased cells. Dental caries or periodontitis arises
from a shift in the microflora and an accumulation of pathogenic bacteria (63)
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Fig 1.2. A model for the transport mechanism of the major structural
proteins of P. gingivalis cell surface filaments. In this model, a
primary form of the major structural proteins of P. gingivalis cell
surface filaments is transported from cytoplasm to periplasm via the
general secretion pathway, where the cysteine residue in the
lipoprotein box is modified by diacylglyceryl transferase (Lgt). The
precursor form is then cleaved at the N-side of the cysteine residue
by signal peptidase II (Lsp). After the major structural proteins are
transported on to the outer face of the outer membrane, they are
processed further by Rgp to yield their mature forms, which
subsequently assemble into filamentous structures. (124)
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FimA Regulation
Several environmental cues modulate the expression of the fimA gene; these
include elevated temperature, hemin concentrations, cell density, serum and salivary
concentrations (150). There is also evidence to suggest that the FimA can positively
regulate its own expression (151) through a two-component system which involves the
fimS and fimR, suggesting multiple mechanisms of regulation control (152).
At the N-termini of the primary translated forms of fimbrillin and the 75 kDa
protein is a 10 (34,153) or 46 and 49 amino acid long peptide extension respectively
(70,108), which is cleaved by arginine specific cysteine proteinase (Rgp). In all six fimA
genotypes, the first 27 amino acids are the same, suggesting that the prosequence of
the primary translated protein of fimA is processed sequentially by several peptidases
(97). The maturation and translocation of fimbrillin and the 75 kDa protein are dependent
on Signal peptidase II, these proteins are transported to the outer membrane by the
lipoprotein sorting system, the mature form of FimA is then autopolymerized to form
fimbriae (124,126) Fig. 1.2.

Mfa Structure and Immunogenicity
An additional interaction is required for P. gingivalis to accrete to the mixed
species biofilm. The short fimbriae (mfaI) provides this interaction (124). When viewed
under the electron microscope, these fimbriae were distinctly short – 5 nm in width and
0.1 to 0.5 µm in length, compared to the FimA which is 4.6 nm in width and 1.3 µm in
length (131). The subunit protein of minor fimbriae (Mfa1) is encoded by the mfa1 gene
(Fig. 1.3.), and the antigenicity and size of the resulting product is different from FimA
(47,138). The ability of minor fimbriae to elicit an immune response has been
demonstrated in its ability to induce IL-1, IL-, IL-6, and TNF- cytokine expression in

7

mouse peritoneal (48). Studies with knockouts of fimA, mfa and mfa:fimA inoculated in
the oral cavities of rats, showed significant suppression of periodontal bone loss when
compared to the P. gingivalis wild-type ATCC 33277 using the mfa1 and mfa:fimA
knockouts. More significant bone loss was observed in the fimA knockout than in the mfa
knockout; additionally, there was no auto-aggregation in the fimA knockout and markedly
lower levels of adherence to single cells, whereas the double knockout completely lost
its adhesive capabilities (138).
The Mfa1 molecule has been shown to be the same as the 75 kDa outer
membrane protein, the 67 kDa major outer membrane protein, and pg-II (a 72 kDa cell
surface protein) reported in several studies. Another minor fimbriae has been isolated
from strain 381 (9) which in contrast to 33277 is 53 kDa and has no immunological cross
reactivity to the 67 kDa minor fimbriae from 33277 (7). Mfa1 has also been shown to be
a receptor for SspB (Streptococcal surface polypeptide) BAR, which is necessary for
optimal coadhesion between P. gingivalis and S. goronii. Antibodies to this protein and
recombinant Mfa1, competitively inhibited P. gingivalis – S .gordonii binding; additionally,
recombinant Mfa1 was found to bind SspB BAR peptide in a dose dependent manner
(112). The degree of P. gingivalis aggregation was found to correlate with the expression
levels of mfa1 and fimA. In particular, the down-regulation of fimA and the up-regulation
of mfa1 are believed to bring about autoaggregation of P. gingivalis; additionally, minor
fimbriae appears to play an important role in microcolony formation by facilitating cell-cell
interactions and the maturation of monospecies biofilms (88).
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Fig 1.3. Schematic diagrams of the downstream genes of fimA (A) and mfa1 (B)
in limited strains. (A) The top line shows the FimA gene cluster of
Porphyromonas gingivalis ATCC 33277 and 381 (fimA genotype I). Below are
P. gingivalis W83 (genotype IV) and OMZ314 (genotype II). Open-reading frames
are represented by arrows indicating their 3′ ends. The fimA sequences of ATCC
33277, W83 and OMZ314 were obtained from GenBank (D42067) and TIGR
GenBank (AB261607), respectively. The downstream sequence of fimD in
OMZ314 is indicated by a box with a broken line; the sequence further
downstream is not yet available. W83 does not produce FimA fimbriae, partly
because of a defect in FimSR, a two-component signal transduction system,
positively regulating their production. (B) A potential mfa1 gene cluster in ATCC
33277 and W83. The gene cluster appears to be composed of at least five
genes, including mfa1, with the same transcriptional direction except that mfa1 is
split into pg0176 and pg0178 by ISPg4 (pg0177), indicated by the solid arrow, in
W83. Therefore, W83 does not produce Mfa1 fimbriae either. The gene fimB
(and its corresponding genes) and mfa2 (and its corresponding gene) are
highlighted as hatched arrows in FimA and Mfa1 gene clusters, respectively. The
number values shown under the genes indicate their lengths in bp (155).
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Hemagglutinin
Hemagglutination in P. gingivalis is a distinctive property, which differentiates it
from other asaccharolytic, black pigmented anaerobes, and is essential for its growth
(99). Hemagglutination is related to the ability of the bacteria to adhere to host cells, and
is particularly significant since P. gingivalis grows faster in cultures with hemin than in
cultures without hemin (118). Hemin accumulation by P. gingivalis directly affects its
pathogenicity, exemplified by the decrease in transcripts of hemagglutinating genes (86)
gingipain enzyme activity (73), and promoter activity of fimbriae gene (150) under heminlimited growth conditions. There are several reported genes that have been
demonstrated to encode hemagglutinin domains, these included: rgpA(HagE), kgp,
(30,100) , hagA, hagB, hagC (86) and hbp35 (55,56,136). Mutants of rgpA, kgp and
hagA, showed decreased abilities to agglutinate erythrocytes, while an rgpA-kgp-hagA
triple mutant had no hemagglutinating activity (100,123).

Hemagglutinin Domains
The adhesion domain coded for by hagA is similar to that encoded for by the
carboxy terminal regions of rgpA and kgp. These adhesin domains are involved in cell
induced hemagglutination as well as platelet aggregation (96,118). Conversely, hagB
and hagC share over 90% homology, in contrast to only 40% with their upstream and
downstream regions (86). HA-Ag2 a cell bound hemagglutinating adhesin, was identified
as one of the common antigens of the species; H1 of HA-AG2 is hemmaglutinin specific
while the F2 domain is fimbriae specific (17). The recombinant form of Hgp44 located
between Ser720 and Arg1138 of RgpA, and present in Kgp and HagA , was
demonstrated to possess the ability to agglutinate erythrocytes, this residue has multiple
domains including Hgp44B which induces hemagglutination, and Hgp44A which likely
functions as a suppressor of hemagglutination – also has the hemagglutinating epitope
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(GVRSPEAIRGRIQGWRQKT) (100) Fig. 1.4. The Hgp44 domains of HagA, RgpA and
Kgp have also been shown to be key adhesion factors for the coaggregation between P.
gingivalis and T. denticola (62). Using phase displayed epitope mapping, a functional
domain of hemagglutination - IALDQTLGIP - was identified in HBP35. The mutant of
HPP35 was non black pigmented, showed decreased autoaggregation and
coaggregation with other bacteria, and had reduced gingipain activity(55).

Hemagglutinin Immunogenicity
Immunoglobulin G (IgG) antibody was demonstrated to react with recombinant P.
gingivalis hemagglutinin with both chronic and generalized aggressive periodontitis
patients. Most of this IgG belonged to the IgG1 and IgG3 subclasses. Interestingly, there
was no relationship with measures of periodontal attachment loss (15). Other studies
have demonstrated that IgG2a and IgG2b, both of which are complement fixing are the
predominant IgG subclass induced by HagB (76). HagB has been demonstrated to
adhere to Human Coronary Artery Endothelial Cells (HCAE) (133), the purified form has
also been found to elicit a protective immune response in the rat bone loss model (72).
Immunization with Hgp44 also provided protective effect against P. gingivalis induced
alveolar bone loss (93). Nasal immunization with the antigenic region of HagA fused to a
Maltose-Binding protein in mice was effective in eliciting IL-4 and IL-5 producing Th2type CD4+ T cells for the induction of serum IgA, IgG, and mucosal IgA antibody
responses. These specific immune responses provided protective immunity against
alveolar bone loss caused by P. gingivalis infection (36).
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Fig 1.4. Inhibitory effect of the so-called hemagglutinating epitope on the
hemagglutinating activity of Hgp44 during transport of gingipain proproteins.
Gingipain proproteins are transported from the cytoplasm to the periplasm
by the Sec-dependent pathway and secreted from the periplasm to the cell
surface by the Por secretion system. (The so-called hemagglutinating
epitope is removed from the proproteins after translocation to the cell
surface. cp, C-terminal portion of prosequence; IM, inner membrane; np, Nterminal portion of prosequence; OM, outer membrane; pro, prosequence;
sp, signal peptide (99).
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Lipopolysaccharides
The lipopolysaccharides of P. gingivalis, were initially demonstrated to have
significantly different low endotoxic properties when compared to enterobacterial LPS
(95), and it was postulated that this difference in endotoxic potency was dependent on
the chemical structure of it’s lipid A. Compositional analysis of the LPS revealed that the
polysaccharide component consisted of rhamnose, glucose, galactose, mannose,
glucosamine and galactosamine (14). P. gingivalis has a novel lipid A structure when
compared to enterobacterial and B .fragilis lipid A. In particular, the backbone of this lipid
A was found to consist of a phosphorylated -(1-6) linked glucosamine disaccharide at
the 1 position of the reducing sugar, additionally the structure lacked an ester linked
phosphate group bound to the hydroxy group at the 4’ position of the nonreducing sugar.
This unique structure was believed to contribute to the mitogenic effects noted on
splenocytes in C3H/HeN and C3H/HeJ mice (103). LPS was further demonstrated to be
comprised of two macromolecules containing different glycan repeating units: O-LPS
(with O-antigen tetrasaccharide repeating units) and A-LPS (with anionic polysaccharide
repeating units) (110).

O LPS
The core oligosaccharide (OS) of O-LPS occurs in two glycoforms: a capped
core containing the site of O polysaccharide attachment and an uncapped form devoid of
O polysaccharide. This core OS of P. gingivalis O-LPS is a highly unusual structure
(109). The O antigen polymerase (OS1142) was shown to differ from the O antigen
ligase (OS1051) by up to 5 additional α-(13)-linked mannose residues attached to the
nonreducing terminal residue of α-mannose at position 4 of the main outer core
glycoform, which forming a capped core. It is believed that the actions of α-1,3 –
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mannosidase (PG1711) may be important for generating the uncapped core from the
capped core or alternately a manosyltransferase (PG0129) may add additional α-1,3
linked Man residues to the shorter uncapped core to generate the capped core (109).

A-LPS
The APS is comprised of a phosphorylated branched D-Man-containing oligomer
composed of an 16- linked D mannose backbone to which 12 linked D-Man side
chains of different lengths at position 3 are attached. It has been suggested that the
synthesis of APS occurs via a wzy (polymerase)-dependent pathway in which
polymerization of repeating units formed on the cytoplasmic face of the inner membrane,
occurs after they are transported or flipped across the cytoplasmic membrane to the
periplasmic face. PG1142 has been shown to be the sole polymerase capable of
polymerizing the O-antigen repeating unit in P. gingivalis (111). The final step in the
assembly of these two different macromolecules is catalyzed by a relaxed-specificity
ligase named WaaL, which is able to attach either a tetrasaccharide repeating unit or a
branched phosphorylated mannan to the lipid A core (114). Recombinant Kgp-RgpBMyc proteins were shown to bind to the LPS fraction of wild-type P. gingivalis in vitro,
suggesting that gingipains may be anchored to the cell surface through surface
polysaccharides (120).

LPS Maturation
Several genes have been implicated as being involved in the formation of
extracellular polysaccharides and glycan additions of gingipain-adhesin complexes –
vimA, vimE, vimF, porR, rfa and ugdA (105,110,120,125,141-143) these mutants lose
colonial pigmentation and show no reactivity to MAb 1B5 (monoclonal antibody which
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react specifically with the modification Manα1-2Manα1-phosphate side chain) (109).
Increased sensitivity to serum killing was observed in APS biosynthesis defective mutant
strains (128). LPS was also found in great abundance in membrane vesicles, these
packaged LPS were capable of penetrating periodontal tissue and eliciting a destructive
host induced immune response (46,92). There is evidence to suggest that LPS
maturation may be linked to a novel PorS secretion system, which includes the Por
family of proteins in addition to LptO which directly effects lipid A structure through
deacylation (18) Fig. 1.5.

LPS Immunogenicity
P. gingivalis LPS has also been shown to activate human monocytes by a CD14dependent mechanism, it has also been demonstrated to activate both human and
mouse TLR2 and TLR2 plus TLR1, as well as TLR4 in transiently transfected cells
expressing mCD14 (25). TLR2–mediated cell activation is believed to occur through a
lipoprotein from the LPS (51). In endothelial and oral epithelial cells challenged with
commercially prepared LPS, several cytokines were produced, in particular: IL- and IL6 in addition to molecules involved in the adhesion of leukocytes to inflammatory sites:
IP-10, MIP-1, ,  ICAM-1 and M-CSF (75).

Gingipains
P. gingivalis produces a novel class of cysteine proteases termed Arggingipain/Arg-X (Rgp) and Lys-gingipain/Lys-X (Kgp) on the basis of their peptide
cleavage specificity at arginine or lysine residues respectively (113). These enzymes are
virulence factors that serve to disrupt the normal host defense mechanism in addition to
their proteolytic destruction of host connective-tissue proteins, including collagen (type I
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and IV) and extracellular matrix proteins such as fibronectin and laminin
(3,12,71,129,134) (Fig. 1.6.). Arg-X is encoded by two separate genes (rgpA and rgpB),
while Lys-X is encoded by a single gene (kgp) (101).
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Fig. 1.5. Proposed role of LptO in a model of the co-ordinated secretion and
attachment of A-LPS and CTD proteins at the cell surface. In this model it is
proposed that lipid A is synthesized in the cytoplasm and linked to the core
oligosaccharide. It is then flipped across the IM by MsbA (PG1719) (Step 1).
The WaaL ligase (PG1051) then attaches either O-antigen or APS (Step 2).
The newly formed LPS is dephosphorylated by lipid A phosphatase (PG1587 or
PG1773) located in the IM (Step 3). The Lpt IM complex (PG0628, PG0501 and
possibly PG0598) detaches the LPS from the IM, and may pass it to a
periplasmic carrier (possibly PG0414) (Step 4), which is thought to be LptA in
E. coli. The Lpt OM complex including PG1405 the putative LptD (Step 5) flips
A-LPS to the outer surface of the OM (Step 6) where it can be deacylated by
LptO (PG0027) with the released fatty acid chain recovered by lateral diffusion
through the pore of LptO (Step 7). The deacylated A-LPS is inserted into the
OM and conjugated to secreted CTD protein in a co-ordinated secretion event
that involves PorSS (Step 8). (18)
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Different Forms of Gingipains
Three enzyme species make up the extracellular Arg-x protease activity in P.
gingivalis W50 – hRrgpA (heterodimer in which the catalytic chain is noncovalently
associated with an adhesin chain, 54 kDa), RgpA (free monomeric catalytic chain) and
mtRgpA (membrane type RgpA which is exclusively identified with the membrane
fraction, 70-80 kDa). RgpB lacks the adhesin coding region of the adhesin chain of
RgpA, and closely resembles the monomeric protease derived from rgpA. RgpB is found
in two forms – RgpB and mtRgpB (21,37,38,115). RgpA and mt-RgpA were
demonstrated to be glycoproteins, isoforms of RgpA and RgpB were found to react
differently with MAb 1B5, in particular RgpA, mt-RgpA and RgpB reacted strongly with
MAb, while no reactivity was observed with HrgpA or RgpB. RgpA was also
demonstrated to possess 20 – 30% (by weight) carbohydrates (23). RgpA was shown to
contain several sugars of varying abundance including: Ara, Rha, Fuc, Man, Gal, Glc,
GalN(Ac), GlcN(Ac) and N-acetylneuraminic acid (NANA) which totaled 14.4% by weight
of protein, while HrgpA totaled 2.1% by weight of protein (Table 1.1.). RgpB isolated
from P. gingivalis W50 rgpA isogenic mutant was found to contain Ara, Rha, Fuc, Gal,
Glc, GlcA and GlcN(Ac) which totaled 10% by weight of protein (23).

Role of Gingipains in the Host Cellular Response
Gingipains are involved in several cellular processes (80) including: growth,
inactivation of cytokines and their receptors, platelet aggregation, attenuation of
neutrophil antibacterial activities, increasing vascular permeability and apoptosis of
gingival epithelial cells (135). It has also been suggested that protease activity may play
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Fig. 1.6. Native proteins degraded by Rgp and Kgp and the relation of
degradation to pathogenicity (69).
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a role in oxidative stress resistance, hemoglobin binding, absorption and heme
accumulation (2,44).
The ability of gingipains to disrupt the host defense mechanism is clearly
demonstrated by their ability to degrade and inactivate immunoglobulins such as IgG,
IgA and secretory IgA and cytokines including TNF and interleukin 6 (10,16). The
generation of radical oxygen species from activated polymorphonuclear leukocytes is
also inhibited by Rgp and Kgp, suggesting that these proteinases can impair cellular
components of the defense mechanisms (3,71).

Structure of Gingipains
Based on the similarity of the nucleotide sequences, the rgpA and kgp genes can
be divided into six DNA regions. Little similarity is observed between kgp and rgpA in the
P region, which includes the prepropeptide and most of the proteinase domain. The CP
region follows the P region and corresponds to the carboxy terminal region of the
proteinase domain. There is 94% identity between rgpA and kgp in this region. There is
also close homology between the A2 and A4 regions that cover most parts of the
carboxy-terminal adhesin domain and shows close similarity (98 and 96% respectively).
The presence of several nucleotide repeats in the carboxy-terminal domain is believed to
facilitate rearrangements (Fig. 1.7.) (69).
The inability of MAb 1B5 to recognize C terminally truncated RgpB (48 to 50 kDa)
(22,40), led to the suggestion that the carbohydrate modification recognized by the MAb
1B5 is in the C terminal domain, and may play a role in the outer membrane attachment
of the enzyme (145). Numerous outer membrane proteins were found to have primary
and secondary structure similarity to the C-terminal domain of RgpB, and were
designated as CTD family; members of this family are attached to the cell surface
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through cell envelope glycans, which are important for proper folding and processing in
order to produce a fully functional enzyme (122).

Gingipains as Processing Enzymes
Arg-X was found to be a major processing enzyme of several outer membrane
proteins including fimbrillin, as it was able to convert prefimbrillin to the mature fimbrillin
in vitro, interestingly the Lys-X was also shown to be abnormally processed in the Rgp
null mutant, suggesting that Arg-X may be involved in the maturation process of Lys-X
(70). There is also evidence to suggest that Arg-X is induced under iron poor conditions
but down regulated under iron rich conditions (137).

Capsule
Encapsulated P. gingivalis has been demonstrated to cause serious forms of
infection; and mice challenged with encapsulated P. gingivalis develop more severe
infections than those challenged with unencapsulated strains (81,139). Capsular
polysaccharides (CPS) (or K-antigens) consists of several sugars including:
galactosamine, glucosamine, glucose, galactosaminuronic acid, mannuronic
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Table 1.1. GC-MS analysis of O-TMS ethers of methyl glycosides showing the molar
ratios of monosaccharides in the oligosaccharides of HRgpA, RgpA, and LPS of P.
gingivalis W50 after methanolysis (23).
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Fig. 1.7. Isoform construction by proteolytic processing and assembly of the
translated products of rgpA, rgpB, and kgp genes (HG66). Open arrows denote
translation of gingipain genes to their proforms. Pro, profragment; Catalytic,
catalytic domatin; HA1, HA2, HA3, HA3/4, HA4, hemmaglutinin/adhesin
subdomains. Inistial and end amino acids of domains are shown. Small numbered
arrows denote the cleavage site amino acid numbers and large arrows denote
proteolytic processing and assembly of the mature enzyme complex, respectively.
The domains with high homology are shown in the same pattern and the
percentage above Pro-Kgp columns denotes homology percentage of the Pro-Kgp
domains for the corresponding Pro-HRgpA domains. Dots attached to mt-RgpA
and mt-RgpB denote polysaccharide chains. Molecular weights of isoforms are
shown in parentheses. (Modified from Potempa et al. (59)
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acid, glucoronic acid and 2 acetamido-2-deoxy-D-glucose (41,121). Six serotypes have
been identified in P. gingivalis (K1 to K6) in addition to several strains that are K- (devoid
of a capsule). Adhesion of P. gingivalis to human pocket epithelial cells depends on the
hydrophobicity of the bacteria, which is lowered by the presence of a capsule. Cells
deficient in capsule have a higher adherence to epithelial cells and show increased autoaggregation, and are usually fimbriated - show peritrichous fimbriae on their surface in
contrast to the poorly adherent strains, which have significantly less fimbriae and are
shorter than well adhering strains (35,77,139,149). There are significant variations
between all six serotypes and limited conservation as revealed by restriction fragment
length polymorphism analysis. DNA sequence analysis of the K-antigen locus of 381
which is syntenic with W83 revealed that pg0109-pg0114 may be important for capsular
expression (39). It was later determined that several essential genes including pg0106
as well as HU (small, basic, heat stable DNA binding protein) are also necessary
capsular expression (Fig. 1.8.). Interruption of pg0106 prevented capsular
polysaccharide synthesis as well as attachment and initiation of biofilm formation in vitro
(11,29).

Immunogenicity of the Capsule
CPS from P. gingivalis serotype K5 are able to bind F. nucleatum cells, and are able
to inhibit coaggregation between these two oral bacteria (116), while K1 capsular
polysaccharides have been shown to elicit chemokine production from phagocytic cells
and may be important for establishing the inflammatory lesion observed during
periodontal disease (24). All serotypes of P. gingivalis were able to induce a T-helper
type 1 (Th1) pattern of cytokine expression. Dentritic cells (DCs) stimulated by K1 and
K2, expressed higher levels of IL-1β, IL-6, IL-12p35, IL-12p40, and IFN-γ at lower
multiplicity of infection (MOI) than DCs stimulated with other strains (146). Vaccination
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with P. gingivalis CPS in the murine model prevented oral bone loss elicited by P.
gingivalis oral challenge (45).

Heme Transport
Iron in the form of hemin is one of the growth requirements for P. gingivalis, this
organism is able to metabolize a broad range of hemin substrates including
methemoglobin, myoglobin lactoperoxidase, and catalase (13). Owing to the toxic nature
of unregulated iron, i.e. is a cofactor for the generation of oxygen radicals from peroxide,
which can contribute to the oxidative stress, encountered by the bacteria; levels of iron
are tightly regulated in bacteria, to provide adequate iron for bacterial growth while
limiting its availability for interaction with peroxide. P. gingivalis does not utilize the
protoporphyrin IX synthetic pathway, rather it uses hemin as a cofactor for fumarate
reductase and cytochromes It must therefore acquire hemin from its environment (106).
Several uptake pathways are utilized for hemin uptake; these include the htr/tlr (127),
hmu (87) iht (27), and a ferrous uptake transporter – FeoB (26,102).

Htr/Tlr Transporter
The htr/tlr locus consists of 5 genes – htrA (periplasmic binding protein), htrB
(permease), htc (ATP binding protein), htrD (unknown function) and tlr (TonB linked
receptor). The htrABCD have sequence similarity to heme transport systems of other
bacteria while the tlr gene has been demonstrated to be essential for growth at low
hemin concentrations. A preprotein is encoded by the tlr gene. At the N terminus of this
Tlr protein is a TonB Box I and Box III motif, these are typical of TonB linked outer
membrane receptors in gram negative bacteria (127).
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Fig. 1.8. Schematic representation of the capsule locus. (A) The position of the
predicted hairpin structure created by base pairing of the 77-bp inverted repeat
is indicated as a segmented line, and predicted promoter regions are shown
with black arrows. The number of base pairs on either side of the hairpin and
those contained within the loop are indicated. The ORF numbers correspond to
TIGR CMR identifications. (B) Sequence and alignment of the 77-bp inverted
repeat (11).
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Hmu Transporter
The hmu locus is composed of six genes, hmuYRSTUV; these encode a novel
hybrid haemin-uptake system. Notably, hmuY encodes a 23kDa iron-repressible outermembrane protein which is upregulated in iron depleted conditions in addition to the
hmuSTUV portion which consists of a putative cobalamin biosynthesis
(CobN)/magnesium chelatase (HmuS), two putative proteins with predicted
transmembrane domains (HmuT and HmuU) (87).

Iht transport
The iht (iron heme transport) locus is comprised of five genes – ihtA (TonB linked
receptor), ihtB (accessory lipoprotein), ihtC (periplasmic binding protein), ihtD
(permease) and ihtE (ATP binding protein) iron heme transport). IhtB has sequence
similarity to the CbiK of S.typhimurium, which is an anaerobic cobalt chelatase. IhtB
contains 13 of the 14 conserved residues that are present in the PPIX ferrochelatase
anaerobic cobalt chelatase class, and has active site residues typical of chelatases. A
substantially increased lag time was observed with heme limited P. gingivalis incubated
with heat inactivated IhtB peptide-specific antiserum prior to inoculation in a medium
containing hemin. This supported the view that IhtB is involved in iron transport into the
cell (27).

FeoB1 Transporter
P. gingivalis has two feoB genes – feoB1 is monocistronic and encodes a protein
of 844 amino acids, the second feoB2 encodes a 725 amino acids. Both proteins share
over 30% identity and 50% similarity with E.coli FeoB, and their genes were transcribed
under excess heme condition with a second gene, pg1296 and mntR, respectively.
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Whereas inactivated feoB2 had no effect on radiolabeled iron uptake, feob1 inactivation
abolished the transport of radiolabeled iron and resulted in a 2-fold decrease in cellular
iron, when grown under excess heme conditions. Additionally, inactivated feob1 in a
murine lesion model of infection rendered the bacterium avirulent, in contrast to the
feob2 mutation, which induced lesions with no significant difference in size (26).

Oxidative Stress
P. gingivalis possesses a low tolerance to oxygen when compared to other
anaerobes (33), though incapable of colony formation on plates incubated aerobically, it
can tolerate aerobic conditions and can grow in the presence of oxygen at
concentrations lower than in air. The presence of a heme rich environment increases its
aerotolerance. When P. gingivalis was grown under an oxygenated environment, there
were accompanying changes in cell morphololgy – bacillary when stressed as opposed
to coccoid, antioxidant enzymes – NADH oxidase, NADH peroxidase and SOD
increased under oxygenated conditions, proteinase activity – Rgp whole cell activity
increased while Kgp whole cell activity decreased, and fermentation end-products (32).
The FeoB1 transporter was demonstrated to impart peroxide sensitivity to
microbial cells. Cells deficient in FeoB1 showed a 40% to 70% reduction in their ability to
grow in the presence of peroxide (102). Similarly in knockouts of the aphC (alkyl
hydroperoxide reductase) which has peroxide scavenging activity, the mutant showed
increased sensitivity to hydrogen peroxide, but exhibited no change in its pathogenic
potential (65). P. gingivalis produces an Rbr-like protein (rubrerythin) which is induced
above its constitutive anaerobic level in response to dioxygen or hydrogen peroxide.
Strains with disrupted rbr showed increased oxidant sensitivity (33). SOD (superoxide
dismutase) expression is dependent on specific environmental conditions; these include
increased temperature, oxygen and alkaline pH. Though this enzyme is crucial to the
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survival of the organism in aerobic environments as well as conditions generated by
specific reactive oxygen species (ROS), it does not protect the organism against
exogenously generated superoxide or human neutrophils (91).

The recA Locus
BCP Plays a Role in Oxidative Stress
The recA locus consist of 6 putative genes – bcp (0.5 kb), recA (1 kb), vimA (0.9
kb), vimE (1.3 kb), vimF (1.2 kb) and aroG (1.1kb), that is part of a single transcriptional
unit. Bacterioferritin co-migratory protein (Bcp) has in several organisms been shown to
play a role in oxidative stress resistance (20,54,147). It belongs to the thiol-specific
antioxidant/alkyl hydroxyperoxidase family, detoxifying hydrogen peroxide in a similar
way to the AhpC (64). The bcp defective mutant from P. gingivalis W83 designated
FLL302, showed increased sensitivity to hydrogen peroxide at concentrations of 0.25mM
when compared to the wild-type, was black pigmented like the parent strain and had
similar rates of hemolysis,  hemolysis and UV sensitivity. This isogenic mutant also
showed a 30% reduction in Arg-X and Lys-X activity during late exponential growth
phase. There was also no detectable difference in the virulence potential of the bcp
defective mutant when compared with the parent strain in the murine mouse model and
demonstrated decreased aerotolerance when compared with the wild-type (67).

RecA is Involved in DNA Repair in P. gingivalis
The recA of P. gingivalis is involved in DNA repair, and the deduced protein
shows high similarity to the other Gram-negative anaerobes (42). The recA isogenic
mutant (FLL32) is non black pigmented and has no detectable β-hemolysis on brucella
blood agar plates, in contrast to wild-type W83 (parent strain), which is black pigmented
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and hemolytic. Additionally, the recA mutant showed increased sensitivity to ultraviolet
radiation and had reduced Arg-X and Lys-X specific proteolytic activities, though the
transcription of these genes was unaffected. Monospecific, polyvalent antibodies against
the gingipains identified them in the extracellular medium and suggest a difference in the
processing of these proteases. This mutant was also significantly less virulent than the
wild-type in the murine model and provided partial protection to animals against a
subsequent lethal challenge by the wild-type strain. There was also increased
autoaggregation of this mutant, suggesting changes in the surface membrane proteins
(2). Using in vitro expression technology (IVET) with pFLL115 (suicide vector containing
erythromycin/clindamycin resistance gene and the promotorless xa-tetA (Q) 2 cassette,
it was demonstrated that the recA gene was expressed during infection of the murine
host (89). The effect of environmental signals on recA promoter activity was examined
using a transcriptional fusion of the recA promoter region with pFLL115. Exposure to
agents that induce DNA damage did not elicit a change in reporter activity, which
remained constant, suggesting that the recA is not controlled by an inducible SOS-like
regulatory system (as observed in E. coli). Growth phase and pH changes had no effect
on recA activity. In contrast, changes in temperature, calcium concentration and iron
levels resulted in significant changes to the recA gene expression levels (90).

Virulence Modulating Gene A
The vimA gene (virulence modulating gene A) is downstream of recA and codes
for a unique 32 kDa protein. When this gene was inactivated by allelic exchange, the
resulting phenotype of the stain (FLL92) was non black pigmented, has reduced Arg-X
and LysX specific proteolytic activity, lacked beta hemolytic and hemagglutinating
activities, showed increased autoaggregation and was nonvirulent when tested in the
murine mouse model. The reduced gingipain activity was not associated with changes in
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the transcription levels of the gingipain genes (1). This is further supported by the
presence of the proenzyme form of the gingipains (105). There was also a late onset of
gingipain activity in FLL92 which was mostly soluble, and had little or no cell-associated
activity (105,143). The recombinant VimA can interact with the gingipains (Fig. 1.9.) in
addition to several proteins, including HtrA, β-lactamase, sialidase and RegT, which are
known in other bacterial systems to be involved in post-translational regulation Table
1.2. (144). There are 26 amino acid residue of VimA on HtrA and hypothetical protein
PG1833, which may be a direct site of protein interaction. Sera from animals immunized
with P. gingivalis were able to recognize VimA, suggesting that the immune system is
exposed to VimA during the course of an infection (144).

Virulence Modulating Gene E
The vimE gene is downstream of vimA and is expressed independently of vimA.
The isogenic mutant of this gene (FLL93) resulted in a phenotype that showed reduced
Arg-X and LysX specific proteolytic activities that unlike FLL92 was not affected by the
phase of growth. A defect in gingipain biogenesis similar to FLL92 was supported by the
presence of the mRNA transcript for the gingipain genes. A 64-kDa immunoreactive
band similar to that observed in FLL92 was observed in FLL923, using antibodies
against the RgpB proenzyme. Dansyl-glutamyl-glycyl-arginyl chloromethyl ketone (DNSEGR-CK), which irreversibly binds the Rgp active site of Arg-X proteases in wild-type P.
gingivalis and FLL92 cells grown to stationary phase, did not label any protein similar in
size to the expected 48-kDa fluorescent band in FLL93 (141).

Virulence Modulating Gene F
The VimF protein coded for by the vimF gene is a putative glycosyltransferase.
The phenotype of the isogenic mutant (FLL95) is similar to that of FLL93, i.e. has
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reduced gingipain, hemagglutinating, and hemolytic activity. The gingipains unlike that
observed in FLL92 are membrane and extracellular associated. The membrane forms
are of high molecular weight; these represent the unprocessed or partially processed
gingipains. Additionally, no immunoreactivity was observed with MAb 1B5 (monoclonal
antibody specific for carbohydrate modifications of membrane associated Rgp and LPS).
Several high molecular weight bands greater than 191-kDA were also observed in the
membrane fraction of FLL95 and FLL93, and represent unprocessed or partially
processed HagA species. This suggests that vimF may be necessary for proper
processing of the hemmaglutinin protein. Fibronectin (plays an important role in cellular
signal transduction by interacting with integrins) was cleaved at significantly lower levels
when incubated with the vimF and vimE, when compared to W83, which completely
degrades fibronectin. Significantly, the vimA defective mutant was unable to cleave
fibronectin, and it has been suggested that the reason for this may be due to absence of
Kgp and RgpA on the surface of the cell (142).

The recA Locus and Adhesion
The effect of protease active extracellular protein preparations from P. gingivalis
on the adhesion properties of human epidermoid carcinoma KB cells, demonstrated that
extracellular protein preparations with gingipain activity induced cell rounding and
detachment from each other and from the surface of the culture dish. The level of cell
death was found to be correlated with the protease-dependent activities of the isogenic
mutants tested (FLL32 and FLL33). Interestingly, the kinetics of N-cadherin cleavage
and loss of cell adhesion was different in FLL32 and FLL33. Preparations from FLL32
(low gingipain activity) did not induce the cytotoxic effects observed for P. gingivalis
FLL33 and W83. The levels of integrin 1 in FLL33 preparations remained unchanged in

32

the first 12 hours of exposure to P. gingivalis FLL33 preparations, however at 24 hours a
decrease in the intensity of the integrin 1 was observed. There were also statistically
significant moderate levels of apoptotic cell death during long-term incubation of KB cells
with extracellular protein preparations from P. gingivalis; suggesting that gingipain
induced cell death may contribute to tissue destruction typical of periodontal disease
(19).

Proteins that Interact With VimA
PG2096, designated regT (regulator of gingipain activity at elevated
temperatures) was determined by in silico analysis to have 62% homology with the gene
for Sgp G protein from Streptococcus mutants; additionally it had several RNA binding
sites but no DNA binding sites. The isogenic regT mutant (FLL205) showed increased
autolysis when compared to the parent strain when grown at 42C up to 24 hours though
there was no significant difference in the growth rate; however, when grown under
oxidative stress, the regT defective mutant was more resistant to hydrogen peroxide
than the wild-type. Gingipain activity of FLL205 was demonstrated to be dependent on
the temperature at which it was grown. At 37C, gingipain activity was lower than the
wild-type, while at elevated temperature, gingipain activity was increased when
compared to the wild-type. Though there was no change in the expression level of
gingipain genes in (127) the wild-type compared with the mutant, immunoblot analysis
showed that the catalytic domain of the Arg-X from cells grown at 42C was more stable
in the FLL205 than the wild-type. These results indicate that RegT facilitates the normal
maturation/processing of gingipains at normal temperature at the posttranscriptional
level (140)
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HtrA in several organisms has been shown to be involved in protein folding and
maturation in addition to degradation of misfolded proteins (58,68). Inactivation of this
gene in P. gingivalis (FLL203) resulted in a phenotype that was similar to the wild-type,
i.e. was black-pigmented and -hemolytic. This mutant strain was more sensitive to
oxidative stress when compared to the wild-type, and this sensitivity was most
pronounced during the stationary growth phase. FLL203 also grew at a slower rate at
37C, but grew more slowly at 42C when compared to the wild-type; additionally, its
growth did not exceed OD600 of 0.9. There was no significant difference in the Arg-X
activity between the mutant and wild-type strain at 37C; however, after heat treatment,
wild-type Arg-X activity increased by 7% while Arg-X activity decreased by 13% relative
to an untreated control. No Arg-X immunoreactive bands were observed in the htrAdefective mutant. These results point to a role for HtrA in gingipain regulation at elevated
temperatures (117).

DNA Damage and Repair
The repair activity of a mutagenic 8-oxoG lesion in P. gingivalis is dissimilar
from E. coli, as enzymatic removal o f8-oxo-G occurs by DNA cleavage several bases
away from the lesion. Greater 8-oxoG repair activity was observed in FLL92 compared
with the wild-type. The cleavage pattern for 8-oxoG lesions was also demonstrated to be
independent of the position of the 8-oxoG within the fragment (66,67). In comparison to
other oral anaerobes, only P. gingivalis demonstrated a different pattern for the
enzymatic removal of 8-oxoG, suggesting that this repair mechanism might be unique to
P. gingivalis. Though our lab previously speculated that the repair mechanism for the 8oxo-G lesion could a nucleotide excision repair like mechanism, further studies have
indicated that this is not the case. The uvrB defective mutant from P. gingivalis was more
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sensitive to UV irradiation that the wild-type strain and there was no difference in
sensitivity to oxidative stress in the uvrB-defective mutant compared to the wild-type.
Additionally, repair of oxidative stress-induced DNA damage was similar for both the
wild-type and the uvrB defective mutant; this rules out uvrB-dependent nucleotide
excision repair as a means of repairing 8-oxo-G lesions. Several lesion specific binding
proteins were observed to bind the oligonucleotide carrying the 8-oxo-G, including
PG10376. These proteins are suggested to form part of a unique mechanism for the
removal and repair of 8-oxo-G lesions (52).
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Fig. 1.9. rVimA interacts with gingipains RgpA, RgpB and Kgp. (a) Eluates from
interaction studies with cell lysates of P. gingivalis W83 and FLL92 in the exponential
phase (E) or stationary phase (S) were separated by SDS-PAGE and stained with
SimplyBlue Safestain. (b–c) Eluates from protein interactions with lysates prepared
from cells grown to late exponential phase were analysed by immunoblotting using
gingipain-specific antibodies: anti-RgpA (b), anti-Kgp (c) or anti-RgpB (d). W83 (–), P.
gingivalis W83 incubated with beads only; FLL92 (–), P. gingivalis FLL92 incubated
with beads only (negative controls) (144).
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Table 1.2. Proteins that interact with recombinant VimA
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Elucidating the Role and Function of the VimA
We have previously shown that inactivation of the vimA gene which is part of the
bcp-recA-vimA-vimE-vimF-aroG operon, alters glycosylation in P. gingivalis and plays an
important role in protease activation in this organism. Furthermore, the gingipain RgpB
proenzyme was secreted in the vimA-defective mutant, whereas both RgpA and Kgp
was missing from the cell membrane (105,143). Protein-protein interaction studies using
the 39 kDa recombinant VimA protein demonstrated interaction with the gingipains. In
addition, other proteins known to be associated with carbohydrate metabolism and
protease maturation also interacted with the rVimA protein (144). Collectively, these data
suggest that VimA may be part of a protein complex that is involved in gingipain
biogenesis/glycosylation, or may modulate other proteins that can directly/indirectly
affect this process or cell surface structures. There is a gap in our understanding of the
effects of VimA on cell surface structures; therefore, we will explore the hypothesis that
the VimA of Porphyromonas gingivalis plays an important role in cell surface biogenesis.
The following specific aims will be used to address the aforementioned hypothesis:

Specific Aim One: Identification of Membrane and Extracellular
Proteins Affected by the VimA Mutation
Our lab has previously shown that VimA is involved in several membrane related
processes, including: gingipain maturation, LPS biosynthesis, and carbohydrate
biosynthesis. SDS PAGE analysis of membrane and extracellular proteins of FLL92
versus the wild-type reveals a differential protein profile, this leads us to hypothesize that
the vimA mutation is affecting the maturation and anchorage of several proteins. We will
explore this hypothesis through mass spectrometric analysis and in silico analysis of
membrane and extracellular proteins.
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Specific Aim 2: Functional Characterization of vimA’s Involvement in
Surface Biogenesis
The auto aggregation phenotype observed in the vimA mutant in addition to its
differential carbohydrate profile points to a likely role in capsular formation, fimbrial
expression and post translational modification of proteins. Using a combination of
electron microscopy, lectin binding assays and bioinformatics, we aim to determine the
involvement of VimA on surface related macro structures

Specific Aim 3: Exploring VimA’s Role as a Possible Acyl CoA N-acyl
Transferase
VimA is predicted by In silico analysis to belong to the Acyl-CoA N-acyl
transferase; additionally, its predicted tertiary structure is similar to the FemXAB family of
proteins which have been demonstrated to be involved in peptidoglycan formation. In
this specific aim we will elucidate the possible role of vimA as a putative acyl transferase
by

3

H labeled palmitic acid assays, antibiotic sensitivity assays, isolation and

characterization of the peptidoglycan and determination of chemical structure variability.
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Summary
The Porphyromonas gingivalis vimA gene has been previously shown to play a
significant role in the biogenesis of gingipains. Further, in P. gingivalis FLL92, a vimA
defective mutant, there was increased auto-aggregation, suggesting alteration in
membrane surface proteins. In order to determine the role of the VimA protein in cell
surface biogenesis, the surface morphology of P. gingivalis FLL92 was further
characterized. Transmission electron microscopy demonstrated abundant fimbrial
appendages and a less well defined and irregular capsule in FLL92 compared to the
wild-type. In addition, Atomic Force microscopy showed a smoother surface for the wildtype strain in contrast to the FLL92. Western blot analysis using anti-FimA antibodies
showed a 41 kDa immunoreactive protein band in P. gingivalis FLL92 which was missing
in the wild-type P. gingivalis W83 strain. There was increased sensitivity to Globomycin
and Vancomycin in FLL92 compared to the wild-type. Outer membrane fractions from
FLL92 had a modified lectin binding profile. Furthermore, in contrast to the wild-type
strain, 9 proteins were missing from the outer membrane fraction of FLL92, while 20
proteins present in that fraction from FLL92 were missing in the W83 strain. Taken
together, these results suggest that the VimA protein affects capsular synthesis, fimbrial
phenotypic expression and plays a role in the glycosylation and anchorage of several
surface proteins.
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Introduction
A variety of bacterial cell surface components including: capsule,
polysaccharides, proteases (gingipains), hemmaglutinin, lipopolysacharides, major outer
membrane proteins and fimbriae contribute to the virulence of Porphyromonas gingivalis
[reviewed in (35,85)]. This organism, a black-pigmented, Gram-negative anaerobe, is an
important etiologic agent of periodontal disease and is associated with other systemic
illnesses including cardiovascular disease (10,12,17,47). Cell surface components like
the fimbriae (3,45,83), lectin-like adhesins (9) and gingipains (42,57,60) are integrally
involved in the adhesion, invasion and colonization of periodontal tissue. In addition, the
gingipains are involved in several cellular processes (33) including: growth, inactivation
of cytokines and their receptors, platelet aggregation, attenuation of neutrophil
antibacterial activities, increasing vascular permeability and apoptosis of gingival
epithelial cells (73). Gingipains consist of a Lysine specific protease (Kgp) and an
Arginine specific protease (Rgp) – which is further subdivided into RgpA and RgpB;
these cleave proteins after arginine residues, and are encoded by the rgpA and rgpB
genes respectively. The mature form of RgpA contains a catalytic domain and a
hemagglutin domain while RgpB possesses only a catalytic domain. Lysine specific
protease (KGP) (28,44,58) – cleave proteins after lysine residues.
Post-translational modifications of surface components like the gingipains,
fimbriae and LPS play a key functional role in regulating the virulence of the organism.
The maturation pathway of the gingipains are linked to the biosynthesis of surface
carbohydrates (56,70) and several other proteins including the PorR (70), PorT (49,67),
Sov (67) and VimA (77,79,80). Arg-X also play a role in processing fimbriae protein
precursors serving as a proteinase for fimbrillin maturation (30,48). The LPS of P.
gingivalis which has been recently shown to contain two macromolecules: O-LPS (O
antigen attached to a lipid A core) and A-LPS (phosphorylated branched mannan
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repeating unit attached to a lipid A core), undergo several stages of assembly including
catalysis by a relaxed-specificity ligase which is able to attach either a branched
phosphorylated mannan or a tetrasaccharide repeating unit to the Lipid A core (63). Lipid
A is also present in several structural forms (32) and is likely a function of strain
differences as well as environmental cues.
The P. gingivalis vimA gene which is part of the recA operon and codes for a 39
kDa protein (putative Acyl CoA N-acyltransferase) has been previously shown to be part
of the maturation pathway for gingipains (1,80). Though the mechanism for gingipain
regulation has not been thoroughly elucidated, we have demonstrated that vimA
modulates the phenotypic expression of the gingipains. Additionally, inactivation of this
gene resulted in a non-black pigmented strain designated P. gingivalis FLL92, which
showed reduced levels of proteolytic, hemagglutinating and hemolytic activities (1,53).
Using a mouse model, the virulence of P. gingivalis FLL92 was shown to be drastically
reduced when compared to wild- type W83 strain. The reduced proteolytic activity
observed in this vimA-defective mutant is as a result of a defect in the post-translational
regulation of these genes. This is further supported by the presence of the proenzyme
form of the gingipains in addition to their unaltered transcription in the vimA-defective
mutant (53). There is also a late onset of gingipain activity in FLL92 which is mostly
soluble with little or no cell-associated activity (53,79). Other studies have shown that the
recombinant VimA can interact with the gingipains in addition to several proteins,
including HtrA, β-lactamase, and sialidase which are known in other bacterial systems to
be involved in post-translational regulation (80). It still remains unclear whether the vimA
gene product is part of a central mechanism that may be involved in the maturation or
post-translational regulation of other cell surface proteins in P. gingivalis.
In the present study, we further characterized the cell surface of the vimAdefective mutant of P. gingivalis. We investigated the role of VimA on capsule and
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fimbriae formation and outer membrane protein expression. In addition, the effect of cell
surface changes on antibiotic resistance was also evaluated.

Material and Methods
Bacterial Strains and Growth Conditions
P. gingivalis strains (W83, ATCC 33277 and FLL92) were grown in either Brain
Heart Infusion (BHI) broth (Difco Laboratories) supplemented with cysteine (0.1%),
vitamin K (0.5 μg/ml) and hemin (5 μg/ml) or in Trypticase Soy Broth containing
menadione and hemin (TSBKH). Solid medium was prepared by supplementation with
1.5% agar and 5% defibrinated sheep blood (Hemostat laboratories). All cultures were
incubated at 37˚C in an anaerobic chamber (Coy Manufacturing) in 80%N2, 10% H2 and
10% CO2. Growth rates were determined spectrophotometrically at 600nm (optical
density).

Biofilm Formation Assay
Biofilm formation was assayed in 96-well microtiter dishes (Lamont personal
communication). Briefly, P. gingivalis was cultured overnight in TSBKH media. One ml of
the overnight culture (mid-log phase) was centrifuged at 11,000 rpm for 2 minutes at
room temperature. The pellet was collected and washed twice with 1 ml of PBS, then
resuspended in a 1 ml mixture of TSBKH and PBS (1:2). Aliquots of the sample were
added to each well. Plates were then incubated with a slight rotation for 24 hours in an
anaerobic chamber, to allow for the development of biofilm. After removal of the culture
supernatant, the plates were washed twice by immersion in distilled water then allowed
to air dry for 1 hour. The biofilm was stained with 0.5% safranin for 15 min (100 µl per
well), then washed twice with distilled water. Ethanol (95%) was added to solubilize the
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safranin which was transferred to a new microtiter dish. Biofilm formation was obtained
by determining the absorbance with a plate reader at 490 nm (11).

Analysis of P. gingivalis Strains by RT-PCR
Total RNA was extracted from P. gingivalis at the early (O.D. 1.0) phase of the
growth cycle, using the SV Total RNA Isolation System (Promega). RT-PCR was
performed using primers specific for the FimA (Fwd – GGCAFAACCCGTTGTAGAAA,
Rve – GACCAAAGAATTGCCGAAAA) and 16S ribosomal gene product (6). The
protocol was done according to the one step RT-PCR kit (Invitrogen) with 1µg of
template RNA in 50µl of RT-PCR mixture. RT-PCR in the absence of reverse
transcriptase served as the negative control.

Protein Electrophoresis and Blotting
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was
performed according to the manufacturers instructions (Invitrogen) on 10% bis-tris
separating gel in MOPS (morpholinepropanesulfonic acid) SDS running buffer. Proteins
on SDS-PAGE gels were electrophoretically transferred to a nitrocellulose membrane
(Whatman Optitran BA-S 85) and the blotted membranes immunostained with polyclonal
anti-FimA (36). Lectin studies using Agaricus bisporus [ABA; specific for Galactose (β
1,3) N-Acetylgalactosamine], Concanavalin A [ConA; specific for α- mannose & αglucose], Dolichos biflorus [DBA; specific for N-acetyl-α-D-galactosamine], Erythrina
cristagalli [ECA; specific for Galactose (β 1,4) N-Acetylglucosamine], Glycine Max [SBA;
specific for N-acetyl-D-galactosamine], Limulus polyphemus [LPA; specific for Sialic Acid
(N-Acetyl neuramic acid)] and Triticum vulgaris [WGA; specific for N-acetyl-β-Dglucosamine], were done according to the recommendations of the manufacturer (Sigma
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Aldrich). In brief, blots were blocked in phosphate buffered saline (PBS) containing 2%
TWEEN for 2 minutes at 20˚C. Blots were then rinsed twice in PBS, and incubated with
1 μg/ml of lectin-peroxidase in PBS containing 0.05% TWEEN, with 1 mM CaCl2, 1 mM
MnCl2, and 1 mM MgCl2 for 16 hours at 20˚C. Surplus lectins were removed by rinsing
with PBS; the blots were developed using the DAB staining kit with nickel enhancement
(Vector Laboratories) (37).

Microscopic Examination
Atomic Force Microscopy (AFM) and transmission Electron microscopy (TEM)
were used to provide detailed visuals of the surface morphology. AFM was done using
W83 and FLL92 stains grown overnight to OD 1.2, washed twice in 0.1M PBS buffer pH
7.4 and mounted on a cover slide. AFM was performed using the Innova Scanning
Probe Microscope (Veeco Instruments Inc) in air using the tapping mode. Images were
captured in the height mode with a resolution of 256x256 (62). Transmission Electron
Microscopy was performed using the Philips Tecnai 12 TEM as per the method of Hyatt
(27). Briefly, Formvar-carbon coated grids were prepared; the Formvar support was
removed by placing the grids in an atmosphere of solvent vapor. Grids were then placed
on a wire mesh in a glass Petri dish with carbon tetrachloride below the wire mesh. One
µl of the serially diluted sample was placed under the carbon side of a 4x5 mm square of
mica (approximately twice the size of an EM grid). The grid was washed in 0.5% acetic
acid then acetone. The carbon film was broken to free the specimen grid, after which the
grid was placed in stain solution - neutral 1% aqueous phosphotungstic acid for 30
seconds. After blotting dry, the grid was examined using the Tecnai TEM (FEI).
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Localization of FimA in P. gingivalis by Immunogold Straining
Anti-FimA antibodies (36) were purified and used at a working concentration of
1:100. The colloidal gold conjugate, 10 nm in size (Aurion), was diluted using incubation
buffer (20mM phosphate buffer, 150 mM NaCl pH7.4, 0.2% BSA, 15mM NaN3) to
1:1000. A checker board titration of primary antibody to immunogold conjugate was
made to identify the optimal working concentration. Processed nickel grids were
subjected to charging of the processed P. gingivalis strains for a period of 1 hour, then
washed 20 times in 0.025M TRIS buffer and lightly blotted. Grids were subsequently
blocked with 5% Bovine serum albumin in 0.025M TRIS buffer for 15 minutes at room
temperature, then incubated in diluted antibody-gold complex for 4 hours at 37oC.
Staining was done using uranyl acetate (0.8g of uranyl acetate dissolved in 10ml of
absolute ethanol) and freshly prepared lead citrate (10-40mg lead citrate, 10ml of filtered
water, 100µl of 10N NaOH). Grids were immersed in uranyl acetate for 7 minutes at
room temperature and then washed, once by immersion in 25% ethanol and twice by
immersion in water. Grids were dried on filter paper for 10 minutes at room temperature,
and then floated on lead citrate drops for 5 minutes. Following two washes by immersion
in 0.02N sodium hydroxide and drying, grids were visualized using the Philips Tecnai 12
TEM.

Hydrophobicity Assay
Hydrophobicity assays of P. gingivalis strains were based on adhesion to
hexadecane according to the method of Grivet (22). Bacteria were harvested during
exponential growth phase by centrifugation at 4˚C for 15 minutes then washed with 0.1M
PBS (pH 7) and resuspended in PBS. The optical density of the samples was adjusted
to 0.85 at 600 nm. Three ml of bacterial suspension was placed in a polystyrene tube to
which 400 µl of hexadecane was added. No hexadecane was added to the control
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suspensions. Suspensions were equilibrated in a water bath at 37˚C, vortexed for two 30
second periods with five second intervals and allowed to stand until the phases
separated. The lower aqueous phase was carefully removed and its optical density
determined at 600 nm. The values obtained were expressed as the percentage of
bacteria remaining in the aqueous phase compared with the control suspension.

Determination of Minimum Inhibitory Concentrations (MIC)
Serial dilutions of antibiotics were used to determine MIC values in broth. These
experiments were done in duplicates. In brief, broth macro dilutions of W83 and FLL92
were carried out using tubes containing 9 ml BHI-HK broth plus 1 ml of antibiotic dilution.
Tubes were examined for turbidity after incubation at 37ºC for 72 hours in an anaerobic
chamber (84). The MIC was taken as the concentration at which no visible growth was
observed.

Labeling of P. gingivalis with [3H]-Palmitic Acid
P. gingivalis cells were labeled according the protocol of Shoji (69). Briefly, 5 ml
cultures of W83 and FLL92 were incubated for 24 hours in BHI-HK in the presence of 50
µCi/ml of Palmitic acid [9,10(n)-3H] (MP Biomedicals). Cells were then centrifuged,
washed in PBS buffer and homogenized using glass beads to derive total proteins.
Protein fractions were subsequently run on an SDS-PAGE gel. Radiolabeled proteins
were detected using autoradiography as previously reported (82).

Bioinformatics Analysis of VimA
Protein modeling of Vim A was conducted using I-Tasser (87,88). The subcellular
location of the protein was predicted from its amino acid sequence using SignalP 3.0
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(50), Phobius (29) and PsortB (19). Protein motifs and domains of VimA were identified
using PPSearch (59) and Superfamily (20).

Cell Fractionation
The Sarkosyl method was used to prepare outer membrane fractions of P.
gingivalis (61). In brief, P. gingivalis cells were harvested from a 500 ml culture during
the exponential and stationary phase of the growth cycle (OD 0.6-1.0 and 1.5-1.8
respectively). Cells were pelleted at 9000xg for 30 minutes at 4ºC then resuspended in 5
ml of 20 mM Tris HCL (pH 7.4), 10 mM EDTA, 10 mM of Nα-p-tosyl-L-lysine
chloromethyl ketone (TLCK) and 1% sodium lauryl sarcosinate. Cells were disrupted by
passage through a French pressure cell at 109 MPa. Whole cells were removed by
further centrifugation at 5000xg for 20 minutes at 4ºC. The outer membrane fraction was
separated by centrifugation (100,000xg for 30 minutes), and then the pellet was washed
three times in 0.5% sodium lauryl sarcosinate and resuspended in 20 mM Tris HCL (pH
7.4). Extracellular fractions were prepared from cell-free culture fluid precipitated with
60% acetone (-20ºC) (80). The protein pellet was resuspended in 7 ml 100 mM Tris-HCL
buffer (pH 7.4) in the presence of 1 mM N-p-tosyk-L-lysine chloromethyl ketone (TLCK),
dialyzed for 48 hours against the same buffer then stored at -20ºC. Total proteins were
harvested from a 50 ml culture during the late exponential phase. Cells were pelleted at
8000xg for 30 minutes then resuspended in 1 ml of 25 mM Tris HCL (pH 8.0) with a
protease inhibitor cocktail tablet (Complete EDTA-free, Roche Indianapolis, IN), RNase
and DNase. Resuspended cells were then transferred to a 2 ml cryogenic tube
containing 1 g of 0.1 mm glass beads. Cells were lysed in a Beadbeater homogenizer
for 4 minutes with 30 second intervals with 1 minute cooling on ice. Samples were then
centrifuged (10,000xg) for 12 minutes 4ºC. The upper aqueous layer containing the total
protein fraction was removed and stored on ice or at -20ºC.
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Digestion of P. gingivalis Wild-type and FLL92 Proteins
Late exponential and stationary membrane proteins were run on a 10% bis-Tris
gel (Invitrogen, Carlsbad, CA) in 1X MOPS running buffer for 1.5 cm, then visualized by
staining with SimplyBlue safe stain (Invitrogen) (25). After destaining in water, the gel
was cut into 1-2 mm slices. Gel slices were subsequently dehydrated in acetonitrile and
dried in a vacuum centrifuge for 30 minutes. The gel slices were incubated for 1 hour at
60ºC in a solution containing 20 µl of 20mM Dithiothreitol in 100mM NH4HCO3 (enough
to cover the gel pieces). The Dithiothreitol solution was replaced with an alkylating
solution (20 µl of 200 mM iodoacetamide in 100 mM NH4HCO3) after cooling the proteins
to room temperature. Gel slices were further incubated at ambient temperature for 30
minutes in the dark, followed by two washes with 150 µl of 100 mM NH4HCO3, then finely
minced with a flame sealed polypropylene pipette tip, dehydrated by the addition of
acetonitrile, and vacuum dried. Following an overnight incubation of the gel pieces with
20 µl digestion buffer [1 µl of mass spectrometry (MS)-grade trypsin
(www.promega.com) in 50 mM acetic acid with 1 µl of 100 mM NH4HCO3], the digestion
reaction was stopped with 10 µl of 5% formic acid. After transferring the digest solution
(aqueous extraction) to a 0.65 ml siliconized tube, 30 µl of 50% acetonitrile with 0.1%
formic acid was added, the mixture was vortexed for 3 minutes, centrifuged and then
sonicated for 5 minutes. The process was repeated and both extractions pooled and
concentrated to 10 µl in a vacuum centrifuge. Peptide extraction was accomplished
using standard C18 ZipTip technology following the manufacturer’s directions (Millipore,
Bedford, MA).

MS and Data Analysis
An LCQ Deca XP Plus system (www.thermo.com) with nano-electrospray
technology (www.newobjective.com) consisting of a reverse phase C18 separation of
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peptides on a 10 cm by 75μm capillary column using Microm Magic RP-18AQ resin
(www.michrom.com) with direct electrospray injection to analyze the extracted peptides
from each gel piece (25). A four part protocol was used for the MS and MS/MS analyses,
this included one full MS analysis (from 450 to 1750 m/z) followed by three MS/MS
events using data-dependent acquisition, where the most intense ion from a given full
MS scan was subjected to collision-induced dissociation, followed by the second and
third most intense ions. The nanoflow buffer gradient was extended over 45 minutes in
conjunction with the cycle repeating itself every 2 seconds, using a 0-60% acetonitrile
gradient from buffer B (95% acetonitrile with 0.1% formic acid) developed against buffer
A (2% acetonitrile with 0.1% formic acid) at a flow rate of 250 to 300 nl/min, with a final 5
minute 80% bump of buffer B before re-equilibration. In order to move the 20 µl sample
from the autosampler to the nanospray unit, flow stream splitting (1:1000) and a Scivex
10 port automated valve (Upchurch Scientific, Oak Harbor, WA) together with a Michrom
nanotrap column was used. The spray voltage and current were set at 2.2kV and 5.0μA,
with a capillary voltage of 25V in positive ion mode. 160°C was used as the spray
temperature for peptides. Data collection was achieved using the Xcalibur software
(Thermo Electron), then screened with Bioworks 3.1. MASCOT software
(www.matrixscience.com) was used for each analysis to produce unfiltered data and out
files. Statistical validation of peptide and protein findings was achieved using X!
TANDEM (www.thegmp.org) and SCAFFOLD 2 meta analysis software
(www.proteomesoftware.com). The presence of two different peptides at a probability of
at least 95% was required for consideration as being positively identified. Confirmation of
individual peptide matches was achieved using the BLAST database
(www.oralgen.lanl.gov)
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Results
In silico Analysis of VimA Reveals Close Similarity to the Fem Family
of Proteins
Using I-TASSER the putative structure of the VimA was modeled, this structure
has a confidence score of 0.54 (Fig. 2.1). Several binding sites were also predicted (Fig.
2.2) the predicted structure is similar to the FemA of Staphylococcus aureus (TM-score
0.81) and FemX of Weisella viridiscens (TM-score 0.89). The gene ontology is predicted
to include a role in one or more of the following: peptidoglycan biosynthetic process,
cellular component biogenesis, cell wall biogenesis, peptidoglycan based cell wall
biogenesis, metabolic process, biosynthetic process, carbohydrate biosynthetic process,
primary metabolic process, carbohydrate metabolic process and peptidoglycan
metabolic process. SignalP 3.0 and PSortb predicted no signal peptide in the VimA
sequence, suggesting that this protein is not secreted. Phobius scores the likelihood of
VimA being a non-cytoplasmic protein at 0.83. Using EMBL protein interaction software
v.8.1, predicts VimA to directly interact with several proteins including several
uncharacterized putative proteins of unknown functional etiology. The cysteine
proteases (PG0506-RgpB) are associated with VimA with a score of 0.808. The
bacterioferritin combinatory protein (BCP) has an interaction score of 0.582 and is
involved in storage of Iron in the form of hydrated ferric oxide. Lys1 mediates lysine
biosynthesis through the enzyme saccharopine dehydrogenase, while RecA has multiple
activities, all related to DNA repair. Position specific iterative protein classifier and
Superfam 3.0 predicts VimA to belong to the DUF482/CH1444 and/or Acyl CoA Nacyltransferase superfamily.
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A

Fig. 2.1. (A) Model of the VimA protein (c score 0.54). (B) Predicted binding site
residues (shown in green): Leu:55 GLY:56 SER:57, PHE:71 ARG:72 ALA:73, VAL:77
HIS:78 MET:84, TYR:95 SER:96 LYS:97, TYR:58 SER:59, ARG:75 ARG:76, HIS:88
PHE:91, and GLN:108 TRP:297
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The Surface Morphology is Affected by the vimA Mutation
Auto-aggregation in P. gingivalis seems to be correlated to the absence of a
capsule and the presence of fimbriae (11). Atomic force and transmission electron
microscopy were used to visualize likely differences between the mutant and the wildtype. Micrographs of W83 (Fig. 2.2. A) and FLL92 (Fig. 2.2. B) revealed differences in
the capsular structure. The Capsule of W83 was solid and well defined in contrast to the
capsule of FLL92 which was less defined and irregular. AFM micrographs of W83 (Fig.
2.2. C) and FLL92 (Fig 2.2. D) showed FLL92 to have distinct fine structures, resulting in
a corrugated appearance, in contrast to the smooth morphology of W83. FLL92 cells
also tended to clump together. Immunogold staining of W83 (Fig. 2.2. E) and FLL92 (Fig.
2.2. F) showed adherence of gold particles to abundant fimbrial appendages in FLL92 in
contrast to few gold particles adhering in W83.

Expression of Fimbrial Genes in the vimA Defective Mutant
The autoaggregation observed in FLL92 could have been as a result of changes
to the fimbrial protein. It is also possible that VimA may also be involved in the post
translational regulation of fimbrial expression. To confirm the presence of the mRNA
transcript for the FimA gene, total RNA was isolated from wild-type and FLL92 strains
grown to stationary phase. Using reverse transcriptase with specific oligonucleotide
primers for an intragenic region of the fimA gene, a predicted 0.6 kb fragment was
amplified for both the wild-type and FLL92 isogenic strain. Immunoblotting of outer
membrane and total protein fractions of FLL92 and W83 with the FimA antibody
revealed strong immunoreactivity with a 41-43 kDa band in both fractions of FLL92 (Fig.
2.3.). This band which corresponds with the expected size of FimA was absent in both
fractions of W83.
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Fig. 2.2 TEM micrographs of W83 (A) and FLL92 (B) showing capsule (CP) with
vesicles (MV). AFM micrographs of W83 (C) and FLL92 (D). Immunogold
localization of P. gingivalis FimA in W83 (E) and FLL92 (F), visualized by TEM after
incubation with anti FimA serum conjugated to 10-nm gold particles (GP).
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33277(TP)

W83 (TP)

FLL92 (TP)

Fig. 2.3. Immunoblot analysis using anti-FimA antibody with outer membrane
(OM) and total protein (TP) fractions of P. gingivalis ATCC 33277, W83 and
FLL92. A 41kDa protein corresponding with the expected size of the FimA
was observed in the vimA mutant.
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There is no Change in the Hydrophobicity or Ability to Form Biofilm in
FLL92
Adhesion to hexadecane was used to determine the hydrophobicity of W83 and
FLL92; ATCC 33277 served as a control (known to form biofilm and auto-aggregates).
There was no change in the hydrophobicity profile of FLL92 compared to W83. 55% of
ATCC 33277 cells adhered to hexadecane, this is reflective of their hydrophilic surface
properties. The ability of the vimA defective mutant FLL92 to form biofilm as quantified
by adherence to the surface of 96 well plates was unchanged when compared to the
W83 (data not shown).

Bacterial Cell Surface/Membrane Modifications Can Alter
Antimicrobial Sensitivity
Several antibiotics with varying targets were employed in antibiotic sensitivity
testing of FLL92. FLL92 showed increased sensitivity to Globomycin (10 µg/ml
compared with 25 µg/ml in W83) and Vancomycin (5µg/ml compared with 10 µg/ml in
W83)

The VimA Affects Outer Membrane Proteins Glycosylated with
Specific Carbohydrate Moieties
Previous reports from our laboratory have documented the changes in the
glycosylation profile of FLL92 compared to wild-type W83 (79). To further confirm the
role of VimA in post translational glycosylation of outer membrane proteins, lectins were
used. Differential lectin bound protein profiles were observed using ConA, DBA, ECA,
LPA and SBA (Fig. 2.4.). No discernable differences were observed using WGA or ABA.
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VimA Affects the Anchorage of Several Membrane Bound Proteins
Mass Spectrometric analysis of membrane fractions of W83 and FLL92 identified
20 proteins that were absent from the wild-type membrane fraction but present in the
FLL92 fraction (Table 2.1.). While 13 of these proteins are hypothetical, PG0083,
PG0581, PG0602, PG0703 and PG1496 are predicted to be involved in transport
(http://www.oralgen.lanl.gov/). Nine proteins were identified as missing from the FLL92
fraction in contrast to the wild-type (Table 2.2.). These included three proteases: RgpA
(PG1768), Kgp (PG1605) and Carboxypeptidase D (PG0212) in addition to PG0554 and
PG1136 which are predicted to be involved in amino acid biosynthesis
(http://www.oralgen.lanl.gov/). PG1857 which is predicted for involvement in glycolysis or
gluconeogenesis (http://www.oralgen.lanl.gov/) was also identified as missing. Twenty
one membrane proteins were identified as having variable spectral counts (Table 2.3.),
corresponding with a fold change of 1.4 or greater. Ten of these proteins showed a
positive fold change in the VimA mutant while 11 showed a negative fold change. The
majority of these proteins were predicted to be involved in cell envelope biogenesis or
transport (http://www.oralgen.lanl.gov/).

Analysis of Missing Membrane Proteins Reveals Several Common
Motifs
Using PPSearch (http://www.ebi.ac.uk/Tools/ppsearch/), several common
domains were identified in the missing proteins identified by MS analysis (Table 2.4.). In
PG1768 (RgpA), PG1605 (Kgp), PG0212 (Carboxypeptidase D) and PG0981
(Hypothetical) the most abundant motifs were myristoylation sites (13, 11, 49 & 37
respectively), Casein Kinase II phosphorylation motifs (19, 14, 29 & 35 respectively) and
Protein Kinase C motifs (15, 16, 27 & 20 respectively).
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191kDa
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Brilliant Blue
stained Gel

Fig. 2.4. Outer Membrane preparations from P. gingivalis W83 and FLL92
were transferred to nitrocellulose, blocked in PBS then incubated with
lectin-peroxidase overnight. Peroxidase activity was detected using the
DAB peroxidase substrate kit. Differential lectin binding was observed
using ConA, DBA, ECA, LPΑ and SBA.
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Table 2.1. MS analysis of aberrantly expressed proteins in FLL92

Identified Proteins

Accession
#

Putative Role/Function

M.W.

W83 S.C.V

FLL92
S.C.V
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conserved hypothetical protein (possible alkaline secretion
protease)
conserved hypothetical protein; possible lipoprotein

PG0083

Transport and binding

56 kDa

0

4

PG0219

Unknown

32 kDa

0

82

hypothetical protein

PG0302

Unknown

47 kDa

0

7

conserved hypothetical protein

PG0332

Unknown

22 kDa

0

1

hypothetical protein

PG0334

Unknown

82 kDa

0

2

conserved hypothetical protein

PG0373

Unknown

30 kDa

0

16

conserved hypothetical protein

PG0410

Unknown

48 kDa

0

4

periplasmic serine protease

PG0535

Proteolysis

53 kDa

0

1

tonB receptor tlr (C-terminal part)

PG0581

Transport

44 kDa

0

4

heme-binding protein/peripheral outer membrane
chelatase
probable biopolymer transport (tolQ) protein

PG0602

Transport and binding

33 kDa

0

4

PG0703

Transport

29 kDa

0

3

hypothetical protein

PG0809

Unknown

16 kDa

0

2

conserved hypothetical protein

PG0922

Unknown

55 kDa

0

7

probable outer membrane lipoprotein

PG1177

Cell wall biogenesis

21 kDa

0

18

conserved hypothetical protein

PG1308

Unknown

100 kDa

0

24

conserved hypothetical protein

PG1496

Transport

99 kDa

0

19

conserved hypothetical protein

PG1772

Proteolysis

98 kDa

0

4

hypothetical protein

PG1790

Unknown

10 kDa

0

1

outer membrane protein (immunogenic 23 kDa
lipoprotein)
probable integral outer membrane protein

PG1793

Cell wall biogenesis

23 kDa

0

44

PG1840

Cell wall biogenesis

24 kDa

0

24

Table 2.2. MS analysis of missing proteins in FLL92

Identified Proteins

Accession #

Putative Role/Involvement

M.W.

W83 S.C.V

FLL92 S.C.V
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carboxypeptidase D / immunoreactive 92 kDa
antigen

PG0212

Proteolysis

92 kDa

3

0

hypothetical protein

PG0554

Cell redox homeostasis

38 kDa

95

0

conserved hypothetical protein

PG0981

Unknown

107 kDa

3

0

branched-chain amino acid aminotransferase

PG1136

Amino acid biosynthesis

38 kDa

11

0

peptidylarginine deiminase

PG1249

Arginine & Proline metabolism

62 kDa

100

0

porphypain polyprotein; lysXproteinase/hemagglutinin

PG1605

Proteolysis/Pathogenesis/DNA
replication & repair

188 kDa

60

0

hypothetical protein

PG1722.1

Unknown

24 kDa

5

0

arginine-specific cysteine proteinase; gingipain

PG1768

Proteolysis/Pathogenesis/DNA
replication & repair

186 kDa

92

0

glyceraldehyde 3-phosphate dehydrogenase

PG1857

Glycolysis/gluconeogenesis

36 kDa

60

0

Table 2.3. MS analysis of proteins with different spectral count values in W83 and FLL92

Identified Proteins

Accession #
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probable outer membrane lipoprotein

PG0916

Putative
Role/Involvement
Cell envelope

M.W.
63 kDa

Fold
Change
7.1

W83 S.C.V
26

FLL92
S.C.V
185

possible outer membrane-associated protein

PG1893

Cell envelope

54 kDa

4

40

10

tonB-linked outer membrane receptor

PG0601

Transport & Binding

85 kDa

3.6

5

18

possible outer membrane-associated protein

PG1424

Cell envelope

61 kDa

3.2

17

54

outer membrane protein

PG0626

Cell envelope

42 kDa

2.6

156

408

possible lipoprotein

PG1600

Unknown

51 kDa

2.2

5

11

outer membrane protein

PG0627

Cell envelope

43 kDa

2

129

256

probable integral outer membrane protein

PG1592

Cell envelope

24 kDa

1.9

29

56

probable integral outer membrane protein

PG1562

Cell envelope

32 kDa

1.6

11

17

tonB-dependent outer membrane receptor

PG0170

Transport

112 kDa

1.5

452

674

receptor antigen B

PG0171

Cell envelope

56 kDa

-1.4

455

316

tonB-linked receptor Tlr

PG0582

Transport

51 kDa

-1.4

14

10

tonB-linked outer membrane receptor

PG1752

Transport

93 kDa

-1.5

15

10

hypothetical protein

PG0197

Unknown

33 kDa

-1.8

9

5

conserved hypothetical protein; possible TonBdependent receptor
outer membrane protein, TonB dependent receptor

PG0899

Transport

100 kDa

-2

8

4

PG0637

Transport

94 kDa

-2.9

52

18

phenylalanine/histidine ammonia-lyase

PG0299

Histidine catabolysis

55 kDa

-3.3

23

7

outer membrane protein

PG1901

Cell envelope

32 kDa

-3.6

29

8

beta-galactosidase

PG0598

127 kDa

-3.8

15

4

hypothetical protein

PG1894

Carbohydrate
metabolism
Unknown

21 kDa

-10.8

43

4

tonB-linked outer membrane receptor

PG1242

Transport

96 kDa

-16
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5

Palmitic Acid Assay Shows VimA to Be Involved in the Acylation of
Proteins
Several outer membrane proteins are lipid modified in P. gingivalis (85). To
determine whether the VimA could play a role in lipid modification of proteins P.
gingivalis was grown in the presence of 3H labeled palmitic acid. No change in the
acylation profile was observed in the total protein fractions of the wild-type or FLL92
grown to exponential phase (Fig 2.5. B). In the extracellular fraction from FLL92 grown to
exponential phase (Fig 2.5. B), a 54 kDa protein was observed in W83 which had 3
times the intensity of that observed in FLL92; while a 27 kDa protein was observed in
FLL92 with twice the intensity of W83 (Fig 2.5. C).
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TABLE 2.4. Predicted motifs present in missing FLL92 membrane proteins
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PG0212
(Carboxypeptidase
D)

PG0554
(Hypothetical
Protein)

PG0981
(Hypothetical
protein)

PG1136
(Branched
Chain AA
transaminase)

PG1249
(Peptidylarginine
deiminase)

PG1605
(Kgp)

PG1722.1
(Hypothetical
protein)

PG1768
(RgpA)

PG1857
(Glyceraldehyde
3-phosphate
dehydrogenase)

MYR *

13

3

11

6

8

49

7

37

7

TYR_PHOS**

0

0

2

0

0

1

0

0

0

CK2_PHOS†

19

5

14

4

5

29

3

25

8

PKC_PHOS††

15

5

16

3

6

27

5

20

5

CAMP_PHOS‡

1

0

1

0

1

2

1

2

1

ASN_GLYC ‡‡

8

4

0

3

5

15

1

17

3

Amidation §
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Fig. 2.5. Autoradiography of total protein (TP) and extracellular fractions (EX) of
W83 and FLL92 grown overnight in the presence of 3H palmitic acid, (A) Brilliant
Blue stained SDS Page gel with W83 and FLL92 TP & EX fractions. (B) 3H
palmitic acid labeled nitrocelluloase membrane with W83 and FLL92 TP & EX
fractions.
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C

D

Fig. 2.5. (continued). (C) Densitometric analysis of 3H lipid labeled proteins of W83 &
FLL92 total protein fraction. (D) Densitometric analyis of 3H lipid labeled proteins of
W83 & FLL92 extracellular fraction. A 54 kDa protein (B1) was three times as abundant
as that observed in FLL92 and the 27 kDa protein (B3) was twice as abundant in FLL92
compared with W83
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Discussion
Membrane integrity is critical to the survival, adaptability and pathogenicity of
bacteria (15,18,86). In this study, we examined the role of VimA on membrane proteins
and structures, with a view to further elucidate its role in modulating virulence in P.
gingivalis. The role of VimA in gingipain maturation, auto-aggregation, hemolysis,
hemagglutination, and LPS synthesis has been alluded to in previous reports (77-80);
however, its role in membrane biogenesis has not been explored. The unique phenotype
of FLL92 led us to hypothesize that VimA plays a significant role in membrane
biogenesis of P. gingivalis and is integral for anchorage and maturation of membrane
proteins.
In silico analysis of the VimA protein predicted a structure that showed similarity
to the Fem family of proteins. These proteins are found in Gram positive bacteria and
are involved in cell envelope biogenesis, particularly in peptidoglycan formation
(7,39,72). Interestingly, this protein is not predicted for secretion or cytoplasmic
localization, suggesting that it is likely transmembrane or periplasmic. Attempts to
localize this protein with antibodies raised against the over-expressed protein in E. coli
have so far proven unsuccessful. The VimA protein could be classified in the
DUF482/CH1444 and/or Acyl CoA N-acyltransferase superfamily. The DUF482/CH1444
is part of the PEP-CTERM system that has sortase-like function and is involved in
bacterial exopolysaccharide biosynthesis (23). Proteins exported in this system have
conserved C-terminal sorting signals that are recognized by a sortase in Gram positive
bacteria (13,14,40,75,76) or an analogous system termed exosortase in Gram negative
bacteria (66). The second predicted family (Acyl-CoA N-acyltransferase) is a broad
family which includes: N-acetyltransferase, N-myristoyl transferase, autoinducer
synthase, FemXAB nonribosomal peptidyltransferases, Ornithine decarboxylase
antizyme-like, AstA-like, DUF1122, EF1021-like. The VimA protein is predicted to belong
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to the FemXAB nonribosomal peptidyltransferase subfamily. Notably, the VimA is
predicted for interaction with the RgpB (score 0.81) in addition to several other proteins.
This is consistent with previous reports which demonstrate that the VimA is able to
interact with RgpB. Interestingly, several proteins including those coded for upstream
and downstream of the vimA are predicted for interaction, it is noteworthy that several
proteins including PG1605 (Kgp), PG0010 (β-lactamase), PG1101 (Alanyl-tRNA
synthase), PG0535 (HtrA), PG1833 (RegT), PG0324 (putative sialidase), and PG1768
(RgpA) that have been previously shown to interact (80) were not predicted for
interaction. This data suggests that the VimA is likely a multifunctional protein, possibly
forming a complex with those proteins encoded at the recA locus, and may modulate
several virulence factors in addition to being involved in the biosynthesis of membrane
proteins and structures.
We have demonstrated in previous studies that compared to the wild-type,
FLL92 autoaggregates (53). Several reports have suggested that the expression of
fimbriae and the absence of a capsule may contribute to auto-aggregation, which in turn
increases the organism’s ability to form biofilm (11). Visible differences were observed
between FLL92 and W83. These differences related to capsular formation and surface
morphology. The capsule of FLL92 was irregular and fuzzy in contrast to the solid
defined capsule of W83. FLL92 also had a corrugated surface morphology compared to
the smooth morphology present in W83. Abundant immunogold particles were observed
in the appendage like structures of FLL92; however, few gold particles were
incorporated in the few surface related appendages of W83. Interestingly, RT-PCR
demonstrated that the fimA gene was similarly expressed in both the wild- type and
vimA-defective isogenic mutant.
The presence of major fimbriae in wild-type W83 was earlier disputed (52), as
screening by immunological means such as bacterial agglutination, ouchterlony
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immunodiffusion and western blotting were all negative; however, electron microscopy
has been used successfully to establish that W83 is poorly fimbriated (24,74). This is in
contrast to highly fimbriated strains such as 33277 and 381 which show positive
immunological fimbrial results and positive visualization by electron microscopy. In P.
gingivalis, there are six classifications of the fimA gene (I, Ib, II, III, IV and V) (4); with the
large majority of patients carrying either type II or IV fimA; interestingly, these genotypic
differences do no correlate with morphological differences in fimbriae (2). W83 is type IV,
whereas 33277 and 381 are type I (52). The relationship between capsular and fimbrial
synthesis is at present unknown in P. gingivalis, however as has been demonstrated in
Klebsiella pneumoniae (41, 65), fimbrial function can be impeded by expression of the
polysaccharide capsule and can be restored by inhibiting capsular synthesis. Capsular
formation may also impede assembly of preformed fimbrial subunits on the bacterial
surface (65). This effect in K. pneumoniae is due to direct physical interaction as
opposed to transcriptional or translational changes; and is in keeping with our own
observations which show that the fimA transcript is made in the wild-type and the
mutant. Therefore, in light of the effect of the VimA mutation on capsular synthesis,
fimbrial function and synthesis may no longer be impeded, resulting in the assembly of
fimbriae on the surface. The presence of the fimA message coupled with undetected
FimA via immunoblotting, may also indicate a role for vimA in protein synthesis and
turnover. Interestingly, these alterations in membrane structure did not affect the
organism’s ability to form biofilm. Taken together, these findings indicate a critical role
for VimA in capsular biogenesis and a likely indirect role in fimbrial synthesis. Further
studies are actively being pursued in our laboratory to elucidate the role of the VimA in
synthesis and regulation of the capsule and fimbriae.
The corrugated surface morphology of FLL92 coupled with previous reports
which demonstrated that though there are more proteins present in the membrane
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fraction, other proteins such as RgpA and Kgp are missing (79,80), could suggest that
this was likely due to the aberrant anchorage and or expression of proteins on the cell
membrane. Our findings revealed twenty proteins that were aberrantly anchored to the
cell wall of FLL92, nine proteins that were missing and twenty one proteins which had
variable spectral count values. These normalized spectral count values correlate to the
relative abundance of these proteins. Of the nine missing proteins, three are involved in
proteolysis, these included: Carboxypeptidase D (PG0212), RgpA (1768) and Kgp
(1605). Glyceraldehyde 3-phosphate dehydrogenase –GAPDH (PG1857) and peptidylarginine deiminase (PG1249) were also missing.
RgpA and Kgp proteinases and adhesins are C terminally processed by
Carboxypeptidase D otherwise known as carboxypeptidase CPG70. This protein shares
C-terminal sequence similarity to cysteine proteinases indicating a common mechanism
for cell surface attachment and secretion (8,81). The absence of this carboxypeptidase
on the surface of FLL92 likely explains why RgpA and Kgp are incorrectly modified and
inactive, existing in the extracellular milieu, but not anchored to the surface. This is in
contrast to the surface bound yet inactive RgpB. GAPDH is a metabolic enzyme of the
glycolytic pathway which phosphorylates glyceraldehyde-3-phosphate to generate 1,3
biphosphoglycerate (34). GAPDH has also been shown to exist on the surface of
bacterial pathogens; functioning as a novel virulence factor in several bacterial species,
by binding host proteins (38,55). In Trichomonas vaginalis, this enzyme binds
fibronectin, plasminogen and collagen (34) while in enterohemorrhagic E. coli and
enteropathogenic E. coli it binds human plasminogen and fibrinogen (16). In Candida
albicans this surface associated enzyme binds to laminin and fibronectin (21). Surface
bound GADPH of Streptococcus oralis has been shown to play a role in P. gingivalis
colonization. The FimA of P. gingivalis is able to bind to GADPH present on the
streptococcal surface (46), this interaction is further used to bind to human oral epithelial
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cells (31). The function of surface bound GADPH in P. gingivalis has not been elucidated
however we speculate that it is likely serving to bind host extracellular matrix proteins
present within the periodontal pocket for proteolytic degradation by the gingipains. It is
also possible that this protein may itself contain a binding receptor for other oral bacteria
so as to allow for biofilm formation and colonization of the oral cavity. Peptidyl arginine
deiminase (PAD) - catalyzes the deimination of the guanidino group from carboxylterminal Arg residues to produce ammonia - is released by P. gingivalis with the
progression and development of adult-onset periodontitis. PAD provides a protective
effect to the bacterium during the acid cleansing cycles of the mouth (68) through the
production of ammonia. The activity of PAD distributed among cells, supernatant and
vesicles has been shown to be growth dependent. It has also been suggested that the
interaction between PAD and Arg-X may arise from Arg-X cleaving anti-adhesive
humoral defense peptides containing internal arginyl residues and other arginine
carboxyl terminal defense peptides, which are then inactivated by PAD (43,64). It is
likely that anchorage of PAD may be dependent on the carboxypeptidase D processing.
The reported interaction between between Arg-X and PAD, leads us to hypothesize that
the enzymatic capabilities of PAD may be compromised as Arg-X is inactive, thus
reducing its efficacy. Further studies are needed to clarify this hypothesis.
When missing proteins were examined for protein motifs using PPsearch - a
protein motif identifier software, myristoylation and phosphorylation sites were in great
abundance in all of the missing proteins. Of the 20 proteins, 13 were hypothetical
proteins, 9 of which had an unknown function. Further, PG0535 (Serine periplasmic
protein) which has been shown to interact with VimA is aberrantly expressed on the
membrane of the FLL92. This study also confirmed in FLL92 the missing membraneassociated RgpA and Kgp as previously reported (79,80). These findings likely explain
the auto-aggregation that is observed in FLL92 and support a role for VimA in anchorage
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and maturation of membrane proteins, possibly through myristoylation or
phosphorylation. The specific interaction between the VimA and missing or aberrantly
expressed proteins is being investigated.
In the vimA defective mutant there is aberrant protein glycosylation (79). It is not
known however whether this aberrant glycosylation is specific to certain carbohydrate
moieties. To clarify the effect of the vimA mutation on glycosylation of outer membrane
proteins, lectins were used. Outer membrane proteins glycosylated with Galactose (β
1,3) N-Acetylgalactosamine, N-acetyl-α-D-galactosamine, Galactose (β 1,4) NAcetylglucosamine, N-acetyl-D-galactosamine and Sialic Acid (N-Acetyl neuramic acid)
were affected by the vimA mutation. Whether this due to the glycosylation of aberrantly
expressed proteins (i.e. proteins that are not present on the wild-type membrane but
present on the membrane of FLL92) or proteins that are incorrectly processed as is the
case with RgpB is still an active area of exploration. These findings suggest that the
VimA plays a role in the correct glycosylation of several membrane proteins.
Since several outer membrane proteins are lipid modified in P. gingivalis (71),
and in keeping with the likely role of the VimA protein as a possible acyl transferase, we
incubated W83 and FLL92 with 3H labeled palmitic acid (lipid donor). The expression
profile of lipid modified proteins in the wild-type and mutant was unchanged. This
suggests that the VimA is either not involved in the acylation of outer membrane proteins
or that there is a redundant mechanism of protein acylation. To this end, PG1355
(putative acyltransferase) was upregulated (3.5 fold change) in FLL92 (microarray data –
unpublished) compared to the mutant. Interestingly, densitometric analysis of the
extracellular fractions of W83 and FLL92 for lipid modified proteins revealed a 54 kDa
protein that was 3 times more abundant in W83 than was observed in FLL92. We also
observed a 27 kDa protein that was twice as abundant in FLL92 as present in W83. The
above findings may indicate a likely role for VimA in the proper acylation of a 54 kDa
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extracellular protein; however, we have not ruled out the possibility that this protein is a
dimer of the 27 kDa protein observed in the extracellular fraction of FLL92. Several
reports have demonstrated that acylation is important for protein folding, protein-protein
interaction as well as ligand induced conformational changes (5,26,54). It is possible that
correct acylation of the 27kDa extracellular protein leads to dimerization. In the vimA
mutant, aberrant acylation of the 27 kDa extracellular protein may occur, resulting in
higher levels of monomeric protein form. Further studies in our laboratory are seeking to
clarify this position.
The expression of additional proteins attributed to membrane biosynthesis and
transport in the VimA mutant suggest that several post translational modification
pathways may be affected by this protein. These modifications could include
myristoylation and glycosylation. Co-translational modifications of proteins could be
attributed to their involvement in signal transduction pathways as molecular switches
associated with glycine rich protein motifs. Myristoylation of proteins are reported to be
involved in Type III secretory system in prokaryotes (51)
The missing and aberrantly expressed proteins in FLL92 suggest that VimA
could have sorting/transport functions. VimA could also function as an acyl CoA Nacyltransferase enzyme involved with protein modification/anchor age of membrane
proteins. In conclusion, our results highlight a putative central role for the VimA protein in
protein modification and transport, possibly triggering cascade reactions that may
modulate the virulence potential of P. gingivalis. The putative multiple functions of the
VimA protein needs further clarification.
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Summary
Several outer membrane structures and secreted proteins contribute to the
invasive potential and virulence of P. gingivalis. We have previously demonstrated that
the VimA protein of Porphyromonas gingivalis is a multifunctional protein involved in
several cellular processes, including gingipain maturation, fimbrial synthesis, lipid
polysaccharide polymerization and anchorage of outer-membrane proteins. In silico
analysis predicts the VimA protein is part of the FemXAB non-ribosomal
peptidyltransferase family which is involved in peptidoglycan synthesis. To further
characterize the VimA, we evaluated its role in peptidoglycan biogenesis and protein
sorting. The peptidoglycan of the vimA mutant and wild-type W83 were isolated and
purified from cells grown to log and stationary growth phase and examined using Atomic
force microscopy and transmission electron microscopy. Hydrolytic enzymes assays
were used to determine differences in the rate of hydrolysis between strains. Mass
Spectrometry was used to identify aberrantly expressed and missing extra-cellular
proteins. Our results indicated structural and compositional differences in the
peptidoglycan of W83 when compared to FLL92. The rate of hydrolysis with lysostaphin
was higher in W83 than in FLL92. Notably, sixty-eight proteins were present only in the
extracellular fraction of FLL92. In the same fraction, there were 16 proteins present both
in the wild-type and mutant; however, they varied in abundance. These observations
suggest that the VimA protein is likely involved in peptidoglycan synthesis, and
corroborates our previous report, which suggests a role for VimA in protein sorting.
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Introduction
Porphyromonas gingivalis is a black pigmented, Gram negative, asaccharolytic,
anaerobic, coccobacilli, which is an important etiologic agent of periodontal disease
(6,8,11,31). Strains from P. gingivalis are classified as either invasive or non-invasive.
Invasive strains have been shown to possess more pathogenic activity in vivo and in
vitro than the non-invasive strains (9,12,20,22). Furthermore, a variety of bacterial cell
surface components including: capsule, polysaccharides, proteases (gingipains),
hemagglutinin, lipopolysacharides, major outer membrane proteins and fimbriae
contribute to cell adherence and virulence of P. gingivalis (26,41,43). These bacterial
surface components may also play a role in resisting phagocytosis by leukocytes (29).
Peptidoglycan, a constituent of the bacterial cell membrane, has been
demonstrated to induce several host inflammatory responses. This heteropolymer is
comprised of glycan strands cross-linked through peptide chains. These chains are of
two types – stem peptides that are linked to the glycan chain, and a cross-bridge that
links stem peptides. There is significant diversity in the composition and sequence of the
cross-bridges and stem peptides across bacterial species (5)
P. gingivalis contains a 51kDa murC gene, which is a homologue of the E. coli
peptidoglycan synthesis gene, and catalyses the first step in the biosynthesis of the cell
wall peptidoglycan (2). An examination of eighteen vesicle preparations from P.
gingivalis identified muramic acid as present in each preparation. These muramic acid
moieties were regarded as low molecular mass compounds, as they were soluble in
TCA [cross-linked peptidoglycans and muramic acid is reported to be insoluble in TCA].
This led the authors to suggest that the products of cell wall turnover – removal of
peptidoglycan fragments from pre-existing cell wall (10), exert turgor on the outer
membrane, which results in the herniation and blebbing of the outer membrane (44) –
formation of vesicles. Several alternate peptidoglycan derived models of vesicle
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formation have also been proposed (7,24). The inflammatory reaction produced in the
host to vesicles may result in part from the presence of muramyl peptides and
lipopolysacharides (44).
The human proteins (Nucleotide-binding Oligomerization Domain) Nod1 and
Nod2 – involved in the intracellular recognition of bacterial products - though initially
thought to recognize bacterial lipopolysacharides, is now believed to specifically
recognize peptidoglycans. Whereas Nod1 recognizes gamma-D-glutamyl-meso-DAP
(found primarily in gram negatives), Nod2 recognizes muramyl dipeptides (MDP)
(14).Two common gene polymorphisms of CARD15 - encodes the Nod2 protein – in
periodontitis patients did not reveal statistical differences between the control group and
the periodontitis group, suggesting no role for these mutations in adult periodontitis (25).
Furthermore, in human embryonic kidney cells stimulated with heat killed P. gingivalis,
weak NOD1 and NOD2 stimulatory activity was observed when compared with other oral
bacteria, suggesting that weak NOD stimulation might be important for the survival of P.
gingivalis in the periodontal pocket (32). Peptidoglycan from P. gingivalis has however
been demonstrated to induce upregulation of CD14 and CD16 in dendritic cells (DCs)
via TLR2 signaling (21). These DCs release higher levels of IL-8 and RANTES at lower
doses than DCs stimulated with fimbriae. Peptidoglycan from P. gingivalis has also been
shown to elicit the production of IL-6 from mouse peritoneal macrophages, and induces
cell death in silkworm tissues via reactive oxygen species (ROS) production (19).
In our previous studies using In silico analysis, the predicted structure of VimA
was similar to the Fem family of proteins (33). These proteins are found in Gram positive
bacteria and are involved in cell envelope biogenesis, particularly in peptidoglycan
formation (4,27,38). Several superfamily prediction software also classified this protein
as belonging to the DUF482/CH1444 (contain determinants for C terminal sorting of
proteins) and Acyl-CoA N-acyltransferase superfamily (broad family which includes the
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FemXAB nonribosomal peptidyltransferases). VimA also interacts with PG1101 (AlanyltRNA synthase) (40), which is likely involved in peptidoglycan synthesis. These studies
led us to speculate that VimA is a possible acyl transferase involved directly in
peptidoglycan biogenesis. To confirm this hypothesis, we examined the morphology of
the peptidoglycan from W83 and FLL92, and utilized several enzymatic assays to
elucidate the possible changes in the peptidoglycan. Mass spectrometry was used to
determine whether the abnormal secretion protein profile observed in FLL92 was limited
to the outer membrane proteins.

Materials and Methods
Bacterial Strains and Growth Conditions
P. gingivalis strains (W83, ATCC 33277 and FLL92) and Enterococcus faecalis
were grown in either Brain Heart Infusion (BHI) broth (Difco Laboratories) supplemented
with cysteine (0.1%), vitamin K (0.5 μg/ml) and hemin (5 μg/ml) (BHIKH) or in Trypticase
Soy Broth containing menadione and hemin (TSBKH). Solid medium was prepared by
supplementation with 1.5% agar and 5% defibrinated sheep blood (Hemostat
laboratories). All cultures, unless otherwise stated, were incubated at 37˚C in an
anaerobic chamber (Coy Manufacturing) in 80%N2, 10% H2 and 10% CO2. Growth rates
were determined spectrophotometrically at 600nm (optical density).

Complementation of vimA
PCR mediated gene replacement was used to complement the vimA defect. In
brief, the ORF of vimA was amplified using primers specific for the vimA. The amplified
fragment was purified by agarose gel electrophoresis, then electroporated into electro
competent FLL92 cells grown to log phase (OD600 of 0.6). Electroporated cells will be
incubated for 12 hours in 1ml of broth then plated on BHIHK-blood plates. Plates were
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then screened after 8 days for black-pigmented colonies. These colonies were
subsequently evaluated for the presence of the uninterrupted vimA gene using PCR.

Peptidoglycan Isolation from W83 and FLL92
P. gingivalis peptidoglycan was prepared using the modified method previously
reported by Isahii (19). In brief, 200ml of P. gingivalis W83 and FLL92 cultures were
centrifuged (9000xg, 10mins at 10C), and the precipitates resuspended in water.
Trichloroacetic acid (10%) was added to the sample and the mixture was incubated at 4º
for 1 hour. The sample was centrifuged (9000xg, 5 min, 10ºC) then washed three times
in water. The precipitate was incubated at 100ºC for 1 hour after being suspended in
50mM sodium acetate buffer (pH 5.3) containing 8% SDS. This was followed by an
overnight incubation at room temperature. After centrifugation (43,000xg, 1 hour, 12ºC),
the sample was washed three times in water and resuspended in Tris HCL containing
2% SDS and proteinase K (50µg/ml) at 37C for 12 hours.

Preparation of Murein Sacculi
Murein Sacculi was prepared from FLL92 and W83 using the method of Yao
(42). Briefly, cells were grown to OD600 of 0.7 representing log phase and 1.5-1.6
representing stationary phase in 2000mls of BHIKH media. Cultures were then
centrifuged at 6000xg for 30 minutes, washed twice then resuspended in phosphate
buffered saline (pH 7.0) containing 1mM magnesium chloride, then washed twice. The
suspension was then boiled in 2% wt/vol SDS for 3 hours and left overnight at room
temperature for 48 hours, after which it was centrifuged for 1 hour at 150,000xg (25ºC)
to pellet the Sacculi. Sacculi were washed three times in deionized water at room
temperature, then dialyzed overnight in one liter of deionized water.
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Lytic Enzyme Assays
Several peptidoglycan hydrolytic enzymes, including muramidase (Sigma), and
lysostaphin (Sigma) were used to determine the susceptibility of peptidoglycan and the
murein sacculi to hydrolysis. In brief, peptidoglycan was suspended in 0.1 M potassium
hydrogen phosphate, pH 7.3 to an approximate absorbance of 0.7 at 580 nm, in a 1cm
light path. One hundred µg/ml was added to the peptidoglycan suspension at zero time
and incubated at 37ºC. The absorbance at 580nm was followed for 24 hour and the
percent hydrolysis was calculated employing the absorbance of an untreated,
peptidoglycan control (3).

Microscopic Examination
Atomic Force Microscopy (AFM) and transmission Electron microscopy (TEM)
were used to provide detailed visuals of the morphology of the murein sacculi. AFM was
done using treated and untreated murein sacculi, isolated from W83 and FLL92 stains
grown to stationary (OD 1.5-1.8) and exponential (OD 0.6 – 0.7) growth phase. Samples
were washed twice in 0.1M PBS buffer pH 7.4 and mounted on a cover slide, then
allowed to air dry. AFM was performed using the Innova Scanning Probe Microscope
(Veeco Instruments Inc) in air using the tapping mode. Images were captured in the
height mode or peak force error (35). Transmission Electron Microscopy was performed
using the Philips Tecnai 12 TEM as per the method of Hyatt (18). Briefly, sacculi were
absorbed to 400- mesh carbon and Formvar coated EM grids. A drop of 2% (wt/vol)
uranyl acetate was used to float the grid for 15s to negatively stain the sample, this was
followed by microscopy using a Philips Tecnai 12 operated under standard conditions
with the cold trap in place (42).
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Bioinformatics Analysis of VimA
ClustalW (ebi) was used to compare the VimA protein and gene sequences to
the FemA, FemB and FemX, while CLC Main Workbench 5 was used to align the
sequence of the missing extracellular proteins derived from Mass spectrometry.

Cell Fractionation
Extracellular fractions were prepared from cell-free culture fluid precipitated with
60% acetone (-20ºC) (40) from W83 and FLL92. The protein pellet was resuspended in
7 ml 100 mM Tris-HCL buffer (pH 7.4) in the presence of 1 mM N-p-tosyk-L-lysine
chloromethyl ketone (TLCK), dialyzed for 48 hours against the same buffer then stored
at -20ºC until used.

Digestion of P. gingivalis Wild-type and FLL92 Proteins
Extracellular proteins were run on a 10% bis-Tris gel (Invitrogen, Carlsbad, CA)
in 1X MOPS running buffer for 1.5 cm, then visualized by staining with SimplyBlue safe
stain (Invitrogen) (16). After destaining in water, the gel was cut into 1-2 mm slices. Gel
slices were subsequently dehydrated in acetonitrile and dried in a vacuum centrifuge for
30 minutes. The gel slices were incubated for 1 hour at 60ºC in a solution containing 20
µl of 20mM Dithiothreitol in 100mM NH4HCO3 (enough to cover the gel pieces). The
Dithiothreitol solution was replaced with an alkylating solution (20 µl of 200 mM
iodoacetamide in 100 mM NH4HCO3) after cooling the proteins to room temperature. Gel
slices were further incubated at ambient temperature for 30 minutes in the dark, followed
by two washes with 150 µl of 100 mM NH4HCO3, then finely minced with a flame sealed
polypropylene pipette tip, dehydrated by the addition of acetonitrile, and vacuum dried.
Following an overnight incubation of the gel pieces with 20 µl digestion buffer [1 µl of
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mass spectrometry (MS)-grade trypsin (www.promega.com) in 50 mM acetic acid with 1
µl of 100 mM NH4HCO3], the digestion reaction was stopped with 10 µl of 5% formic
acid. After transferring the digest solution (aqueous extraction) to a 0.65 ml siliconized
tube, 30 µl of 50% acetonitrile with 0.1% formic acid was added, the mixture was
vortexed for 3 minutes, centrifuged and then sonicated for 5 minutes. The process was
repeated and both extractions pooled and concentrated to 10 µl in a vacuum centrifuge.
Peptide extraction was accomplished using standard C18 ZipTip technology following the
manufacturer’s directions (Millipore, Bedford, MA).

MS and Data Analysis
An LCQ Deca XP Plus system (www.thermo.com) with nano-electrospray
technology (www.newobjective.com) consisting of a reverse phase C18 separation of
peptides on a 10 cm by 75μm capillary column using Microm Magic RP-18AQ resin
(www.michrom.com) with direct electrospray injection to analyze the extracted peptides
from each gel piece (16). A four part protocol was used for the MS and MS/MS analyses,
this included one full MS analysis (from 450 to 1750 m/z) followed by three MS/MS
events using data-dependent acquisition, where the most intense ion from a given full
MS scan was subjected to collision-induced dissociation, followed by the second and
third most intense ions. The nanoflow buffer gradient was extended over 45 minutes in
conjunction with the cycle repeating itself every 2 seconds, using a 0-60% acetonitrile
gradient from buffer B (95% acetonitrile with 0.1% formic acid) developed against buffer
A (2% acetonitrile with 0.1% formic acid) at a flow rate of 250 to 300 nl/min, with a final 5
minute 80% bump of buffer B before re-equilibration. In order to move the 20 µl sample
from the autosampler to the nanospray unit, flow stream splitting (1:1000) and a Scivex
10 port automated valve (Upchurch Scientific, Oak Harbor, WA) together with a Michrom
nanotrap column was used. The spray voltage and current were set at 2.2kV and 5.0μA,
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with a capillary voltage of 25V in positive ion mode. 160°C was used as the spray
temperature for peptides. Data collection was achieved using the Xcalibur software
(Thermo Electron), then screened with Bioworks 3.1. MASCOT software
(www.matrixscience.com) was used for each analysis to produce unfiltered data and out
files. Statistical validation of peptide and protein findings was achieved using X!
TANDEM (www.thegmp.org) and SCAFFOLD 2 meta analysis software
(www.proteomesoftware.com). The presence of two different peptides at a probability of
at least 95% was required for consideration as being positively identified. Confirmation of
individual peptide matches was achieved using the BLAST database
(www.oralgen.lanl.gov)

Results
VimA is Closely Related to the FemX of Weisella viridescens
The phylogeny suggests that VimA (0.52) is closer in relation to FemX (0.45)
than FemB (0.32) and FemA (0.29) (FemA). Additionally, several consensus sequences
were identified in both VimA and FemX, these included1: RY*E**RO, KL****RDG****S,
and EG*LL (Fig. 3.2.).

VimA Affects the Secretion of Several Extracellular Proteins
Mass spectrometric analysis was done to determine whether the differential
protein profile observed previously in FLL92 (33), was unique to the membrane proteins
or whether this mutation also affected the extracellular protein fraction. Mass
Spectrometry of membrane fractions of W83 and FLL92 identified 15 proteins that were
present in the extracellular fraction but absent in W83 (Table 3.1.) and 68 proteins that
were present in the extracellular fraction of FLL92 (Table 3.2.) but absent in W83. The
majority of aberrantly expressed proteins were predicted for involvement in energy
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metabolism, while the remainder was predicted to be involved in proteolysis, protein
binding and transport, DNA metabolism or were hypothetical. Of the fifteen proteins
identified as missing, six were predicted to play a role in cell envelope biogenesis; while
two - PG0468 and PG1357 were predicted to be involvement in protein targeting and
transport. Six of these proteins were hypothetical. Seven extracellular proteins were
identified in FLL92 as having spectral count values with negative fold changes (fc) of 1.2
or greater (Fig 3.3.) - RgpA (PG1768, fc 1.2), Kgp (PG1605, fc 6.6), Carboxypeptidase D
(PG0212, fc 28), Peptidylarginine deiminase (PG1249, fc 12.1), Hemmaglutinin
(PG1602, fc 22.3), TonB-dependent OM receptor (PG0170, fc 285), and a hypothetical
protein (PG0554, fc 50.7).
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Fig 3.1. Phylogram of VimA, FemA, FemB & FemX shows a close relationship of
VimA to FemX

Fig 3.2. Several consensus sequences are present in both VimA and FemX
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The terminal residues from the 15 missing extracellular proteins were examined
to determine whether a common sequence was present in each. No common domain
was present in all these proteins (Fig 3.4). Using PPSearch
(http://www.ebi.ac.uk/Tools/ppsearch/), several common domains were identified in the
fifteen extracellular proteins identified by MS analysis (Table 3.4.). Casein Kinase II
phosphorylation motifs, Protein Kinase C motifs and myristolation motifs were most
abundant.

Complementation of the VimA Defect
The VimA defect was complemented using a PCR mediated replacement
strategy. Several black pigmented colonies were identified on blood agar plates after
electroporation and incubation with the ORF of VimA, these were designated FLL92C,
FLL92B and FLL92D. FLL92B and FLL92D was further characterized and shown to
have the characteristic phenotype of W83. FLL92C became hemolytic and black
pigmented much later than wild-type W83 (+5 days) and autoaggregated when
incubated in BHI broth. Notable, its gingipain activity was marginally higher than FLL92
in log phase. The VimA gene from this strain was sequenced in order to determine
whether a mutation in the gene accounted for this phenotype. Two mutations were
observed in FLL92C at positions 5 and 6, where CC was replaced by AG. The translated
product of this gene contained valine rather than isoleucine at the third amino acid
position.
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Table 3.1. MS analysis of aberrantly expressed proteins in FLL92 extracellular
fraction
Identified Proteins (68)

Accession
#

Putative
Role/Function

M.W.

W83
S.C.V

FLL92
S.C.V

Hypothetical protein

PG0027

Unknown

25 kDa

0

2

UDP-3-O-acyl-GlcNAc deacetylase/(3R)hydroxymyristoyl-acp-dehydratase

PG0060

Fatty acid
biosynthesis

52 kDa

0

3

Nitrogen assimilation regulatory protein
(immunoreactive 47 kD antigen PG120)

PG0136

Transcription

47 kDa

0

12

Endothelin converting enzyme/neprilysin
(PepO)
NADH oxidase/peroxidase

PG0146

Proteolysis

79 kDa

0

2

PG0160

104 kDa

0

7

Probable outer membrane protein (Omp85
analog)
Uroporphyrinogen-III synthase

PG0175

Energy
metabolism
Cell envelope

102 kDa

0

5

28 kDa

0

7

Hypothetical protein

PG0227

Biosynthesis of
cofactors
Unknown

Translation initiation factor IF-2

PG0230

Translation

Conserved hypothetical protein

PG0264

Polyferredoxin

PG0276

Probable dipeptidyl peptidase

PG0185

11 kDa

0

4

108 kDa

0

2

Unknown

39 kDa

0

4

30 kDa

0

2

PG0291

Energy
metabolism
Proteolysis

101 kDa

0

2

Conserved hypothetical protein

PG0293

Unknown

15 kDa

0

3

DNA-mismatch repair protein

PG0350

DNA metabolism

DNA-directed RNA polymerase subunit beta

PG0360

Transcription

ATP-dependent DNA helicase

PG0381

ATP-dependent ClpX-related protease
Ferredoxin oxidoreductase beta subunit
Conserved hypothetical protein

95 kDa

0

9

142 kDa

0

2

DNA metabolism

82 kDa

0

4

PG0382

Proteolysis

46 kDa

0

16

PG0394

37 kDa

0

2

PG0411

Energy
metabolism
Unknown

52 kDa

0

2

Conserved hypothetical protein

PG0452

Unknown

54 kDa

0

49

Pyruvate ferredoxin/flavodoxin oxidoreductase

PG0498

132 kDa

0

2

Hypothetical protein

PG0510

Energy
metabolism
Hypothetical

34 kDa

0

5

Beta-galactosidase

PG0598

127 kDa

0

11

DNA topoisomerase I

PG0680

Energy
metabolism
DNA metabolism

90 kDa

0

17

Acyl-CoA dehydrogenase (coenzyme A
dehydrogenase)

PG0696

Metabolic
process

65 kDa

0

2

Probable Xaa-Pro dipeptidase

PG0795

Proteolysis

44 kDa

0

4

Beta-galactosidase

PG0799

116 kDa

0

2

Translation elongation factor G protein

PG0832

Energy
metabolism
Translation

80 kDa

0

2

Calcium ion-transporting ATPase

PG0838

118 kDa

0

2

Threonyl-tRNA synthetase

PG0888

Transport &
binding
Translation

75 kDa

0

7

D-lysine 5,6-aminomutase alpha subunit

PG0955

57 kDa

0

6

Butyryl-CoA dehydrogenase

PG0958

42 kDa

0

7

Alanine racemase; N-acetylymuramoylalanyl-Dglutamate-2,6,-diaminopimelate-D-alanine-Dalanine ligase
Conserved hypothetical protein

PG0976

Energy
metabolism
Fatty acid
metabolism
Cell envelope

92 kDa

0

2

PG0981

Unknown

107 kDa

0

9
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Ribonucleotide reductase alpha subunit

PG1010

DNA replication

96 kDa

0

6

Probable long-chain fatty-acid-Coenzyme A
ligase (long-chain acyl-CoA synthetase)

PG1028

Metabolic
processing

69 kDa

0

3

Transferase protein

PG1029

43 kDa

0

7

Xaa-Pro aminopeptidase

PG1071

Transposon
functions
Proteolysis

67 kDa

0

14

Hypothetical protein

PG1089

Unknown

80 kDa

0

17

GTP-binding protein (possible membrane
protein)
Conserved hypothetical protein

PG1097

66 kDa

0

2

PG1128

Signal
transduction
Unknown

47 kDa

0

5

Thiol protease (PrtT related)

PG1251

Proteolysis

93 kDa

0

2

O-succinylbenzoate--CoA ligase

PG1330

Biosynthesis of
cofactors

40 kDa

0

9

Magnesium-protoporphyrin Omethyltransferase; cobalamin biosynthesis
protein N
Aminomethyltransferase (glycine cleavage
system T protein)

PG1359

Biosynthesis of
cofactors

163 kDa

0

2

PG1364

Energy
metabolism

40 kDa

0

16

Nicotinate-nucleotide pyrophosphorylase
(quinolinate phosphoribosyltransferase)

PG1377

Biosynthesis of
cofactors

30 kDa

0

4

Bacteroides aerotolerance operon protein, batD

PG1385

67 kDa

0

2

Fumarate reductase/succinate dehydrogenase
flavoprotein subunit
Cell division protein (ATPase)

PG1413

72 kDa

0

7

PG1430

Adaptations to
atypical
conditions
Energy
metabolism
Cell division

96 kDa

0

2

Hypothetical protein

PG1448

Unknown

15 kDa

0

21

Conserved hypothetical protein

PG1496

Transport

99 kDa

0

2

ABC transporter, ATP-binding protein, MsbA
family; MSD-NBD fusion protein

PG1497

Protein transport
& binding

70 kDa

0

4

Hypothetical protein

PG1504

Protein binding

53 kDa

0

2

Immunoreactive 46 kDa antigen PG99

PG1572

Unknown

46 kDa

0

6

Enolase (phosphopyruvate hydratase)(2phosphoglycerate dehydratase) (laminin
binding protein)
Urocanate hydratase

PG1593

Energy
metabolism

46 kDa

0

22

PG1630

74 kDa

0

2

Na+/H+-exchanging protein (Na+/H+ antiporter)

PG1634

49 kDa

0

4

Polyphosphate kinase

PG1640

Energy
metabolism
Transport &
binding
Polyphosphate
biosynthesis

81 kDa

0

3

30S ribosomal protein S8

PG1677

Translation

15 kDa

0

4

30S ribosomal protein S3

PG1684

Translation

28 kDa

0

2

50S ribosomal protein L2

PG1687

Translation

30 kDa

0

3

30S ribosomal protein S7

PG1693

Translation

18 kDa

0

2

Hypothetical protein

PG1783

Cell redox,
homeostasis

39 kDa

0

2

LPS-modified surface protein P59

PG1838

Cell envelope

61 kDa

0

38

Hypothetical protein

PG1867

Unknown

51 kDa

0

19

Hypothetical protein

PG1899

Hypothetical

27 kDa

0

6

Conserved hypothetical protein

PG1927

Unknown

214 kDa

0

3

Excinuclease ABC subunit A

PG1934

DNA metabolism

106 kDa

0

6
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FLL92

Fig 4. Extracellular proteins with different S.C.V

W83
PG0170 (TonB- dependent OM receptor)
PG0554 (Hypothetical protein)
PG0212 (Carboxypeptidase D)
PG1602 (Hemmaglutinin)
PG1249 (Peptidylarginine deiminase)
PG1840 (Probably integral OMP)
PG1605 (Kgp)
PG0180 (Probable zinc protease)
PG0361 (DNA directed RNA polymerase)
PG0322 (Conserved hypothetical protein)
PG1768 (RgpA)
PG1902 (Hypothetical protein)
PG1699 (Hypothetical protein)
PG1136 (Branched chain AA transaminase
PG0082 (Conserved hypothetical protein)
PG0461 (RgpB)
PG0899 (Possible TonB dependent receptor)
PG1639 (Alpha-L-fucosidase)
PG1284 (Conserved hypothetical protein)
PG0074 (DEAD BOX-related helicase)
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Fig. 3.3. Extracellular proteins with different S.C.V
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Table 3.2. MS analysis of missing proteins in FLL92 extracellular fraction
Identified Proteins (15)

Accession #

Putative
Role/Function

M.W.

W83

FLL92

S.C.V
231

S.C.V
0

Receptor antigen B

PG0171

Cell envelope

56 kDa

Conserved hypothetical protein

PG0375

Translation

144 kDa

5

0

Preprotein translocase subunit A
protein
Glutamine-hydrolyzing carbamoylphosphate synthase large subunit

PG0468

Protein targeting

126 kDa

5

0

PG0484

Arginine
biosynthesis

120 kDa

3

0

Hypothetical protein

PG0552

Unknown

37 kDa

10

0

Hypothetical protein

PG0592

Unknown

45 kDa

29

0

Heme-binding protein/peripheral outer
membrane chelatase
Outer membrane protein

PG0602

Cell envelope

33 kDa

10

0

PG0626

Cell envelope

42 kDa

10

0

TonB-dependent receptor HmuY

PG1357

16 kDa

9

0

Probable integral outer membrane
protein P20
Glyceraldehyde 3-phosphate
dehydrogenase
Conserved hypothetical protein

PG1592

Transport &
binding
Cell envelope

24 kDa

2

0

36 kDa

2

0

PG1875

Energy
Metabolism
Unknown

123 kDa

3

0

Hypothetical protein

PG1894

Unknown

21 kDa

2

0

Outer membrane protein

PG1901

Cell envelope

32 kDa

7

0

Conserved hypothetical protein

PG1938

Unknown

61 kDa

7

0

PG1857
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Table 3.3. Predicted post translational motifs in missing FLL92 extracellular
proteins
Proteins
PG0171

MYR
*
4

TYR_
PHO
0

CK2_
PHO
6

PKC_
PHO
0

CAMP_
PHOS
0

ASN_
GLYC
2

Amid
ation
0

PG0375

18

0

18

15

0

22

0

PG0468

7

0

20

23

3

4

4

PG0484

15

17

7

1

3

0

PG0552

6

1

3

1

0

1

0

PTS-HPR
Rib S2
ATP_GTP_A
SECA
CPSASE 1
CPSASE 2
0

PG0592

5

0

0

5

1

3

0

0

PG0602

3

0

2

4

0

2

0

0

Unique
0

PG0626

8

1

5

5

0

0

0

OMPA_1

PG1357

2

0

1

6

0

0

1

ATP_GTP_A

PG1592

8

0

2

4

0

1

0

0

PG1615

4

0

5

3

2

2

0

0

PG1857

7

0

8

5

1

3

0

GAPDH

PG1875

16

0

17

19

2

7

0

RGD

PG1894

5

1

1

0

0

0

1

0

PG1901

1

0

3

5

1

2

1

0

PG1938

23

0

5

8

0

4

0

0

(MYR -N-myristoylation site, TYR_PHOS -Tyrosine kinase phosphorylation site,
CK2_PHOS -Casein kinase II phosphorylation site, PKC_PHOS - Protein kinase C
phosphorylation site, CAMP_PHOS - cAMP and cGMP-dependent protein kinase
phosphorylation site, ASN_GLYC - N-glycosylation site, Amidation - Amidation site,
PTS-HPR - Serine Phosphorylation site signature, Rib S2 - Ribosomal protein S2
signature, SECA - SecA Family signature, ATP_HPR - ATP/GTP-binding site motif
A, CPSASE 1 - Carbamoyl-phosphate synthase subdomain signature 1, CPSASE 2
- Carbamoyl-phosphate synthase subdomain signature 2, OMPA_1 - OMPA-like
domain, GAPDH - Glyceraldehyde 3-phosphate dehydrogenase active site, RGD –
Cell attachment sequence)
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Fig. 3.4. Sequence alignment of the 15 missing extracellular proteins in FLL92
identified by Mass Spectrometric analysis. No unique sequence was common to all
proteins.
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Peptidoglycan from W83 is Hydrolyzed Faster than FLL92
To determine whether the peptidoglycan of FLL92 was chemically dissimilar to
that of FLL92, several lytic enzymes including lysozyme and lysostaphin were used (Fig
3.8). No significant change was observed between the wild-type and FLL92 using
lysozyme; however, with the lysostaphin treated peptidoglycan, the rate of hydrolysis in
W83 was twice that observed in FLL92 (lifetime of W83 - 270.47 ± 21.6; lifetime of FLL92 –
540.43 ± 82)

The Murein Sacculi from FLL92 Differs from W83
TEM and AFM were used to determine the morphology and topography of the
peptidoglycan Sacculi. The Sacculi from FLL92 when compared to the wild-type was
distinctly different, as it possessed a homogeneously uneven surface with numerous
contours. Sacculi from W83 were on average 100nm longer than those observed in
FLL92 (Fig. 3.6 and Fig. 3.7.). Murein sacculi from both strains was subsequently treated
with 15µg/ml of lysostaphin for ten minutes and imaged via AFM. Treated W83 were
visibly different from the untreated control, as numerous contours were visible on the
surface. In FLL92, the morphology of the treated samples was similar to the control.
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W83

FLL92

117
Fig. 3.5. Murein Sacculus Differs in FLL92 Compared to the wild-type
Transmission Electron Microscopy (TEM) was used to visualize the peptidoglycan sacculi of W83 and FLL92 strains, grown to late
OD. Morphological differences were observed in FLL92, when compared to W83
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W83
Channel: Height

FLL92
Channel: Height

Fig. 3.6. Sacculi Topography of W83 and FLL92

W83
Channel: Peak Force Error

FLL92
Channel: Peak Force Error
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W83 Treated

Fig. 3.7. Sacculi of W83 and FLL92, after 10min Treatment with 16μg/ml of Lysostaphin
FLL92 Treated

Fig. 3.8. Peptidoglycan from W83 is Hydrolyzed Twice as Fast as FLL92

120

Discussion
In this study, we report that the peptidoglycan of FLL92 and the protein profile
of the extracellular fraction are altered when compared to wild-type W83. VimA, a gene
downstream of recA - encodes a 32 kDa protein. When inactivated, the phenotype of the
mutant strain (FLL92) was non black pigmented, had reduced Arg-X and LysX specific
proteolytic activity, lacked hemolytic and hemagglutinating activities, showed increased
autoaggregation and was nonvirulent (1). Recently, the vimA gene was also shown to be
involved in capsular and fimbrial biogenesis (33).
The phylogenetic tree comparing VimA to the FemABX proteins, suggests that
FemX (0.45) is closer in relation to VimA (0.52) than the other Fem proteins. Members of
the FemABX family are novel ribosomal Peptidyl transferases that are involved in the
interchain peptide bridges of the peptidoglycan. Though primarily found in Gram positive
bacteria they are observed in a few Gram negative bacteria, particularly the pathogenic
spirochetes (13,15,15). FemX catalyzes the transfer of L-Ala onto the cytoplasmic UDPN-acetylmuramyl-peptapetide (UDP-MurNAc-pentapetide) in contrast to the other Fem
family members, which exclusively or preferentially transfers amino acids to membrane
bound peptidoglycan precursors (28,36). The Kinetics of the FemX involves the
sequential binding of UDP-MurNAc-pentapeptide and the Ala-tRNA to FemX, followed
by the transfer of Ala to the -amino group of L-Lys in the pentapeptide stem and the
subsequent release of the UDP-MurNAc-hexapeptide reaction products and the tRNA
(36).
Several reports have indicated a role for the peptidoglycan in eliciting the host
immune response (19,21); however, much remains unknown with regards the structural
dynamics of the peptidoglycan in P. gingivalis and the enzymes involved in its
biogenesis. Notably, there are no reported orthologs for the Fem family of proteins in P.
gingivalis. The relative molar ratios of the glycan residues was previously reported to be
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considerably lower in P. gingivalis when compared to Bacteroides spp, Pseudomonas,
Actinobaccillus and Actinomycetes, suggestive of higher tetrapeptide to muramic acid
ratios. The amino acid composition of this tetrapeptide contained Alanine,
Diaminopimelicacid (DAP), Glycine and Lysine (17). Interestingly, previous studies in our
lab have shown that recombinant VimA is able to interact with PG1101 (Alanyl t-RNA
synthetase) (40). This finding is consistent with our in silico analysis, which suggests that
VimA may have FemX function, as it would be expected to bind the Ala-tRNA and the
UDP-MurNAc-pentapeptide. The conserved domains identified in both FemX and the
VimA - RY*E**RO, KL****RDG****S, and EG*LL, may represent binding/interaction sites.
TEM and AFM microscopy showed morphological differences between W83
and FLL92. The sacculi from FLL92 was on average shorter in length than those
observed in FLL92, and these sacculi also appeared granular in contrast to the smooth
topography present in the wild-type. When wild-type sacculi were treated with
lysostaphin (endopeptidase which specifically cleaves pentaglycine cross bridges) for
ten minutes, the surface of W83 showed signs of stress with several contours indicative
of hydrolysis, while the FLL92 sacculi showed no discernable change. In peptidoglycan
assays using Lysozyme (catalyzes the hydrolysis of 1, 4-beta-linkages between Nacetylmuramic acid and N-acetyl-D glucosamine) the percentage of hydrolysis was
unchanged for the wild-type and mutant. Using lysostaphin, the rate of hydrolysis was
two times that of FLL92, suggesting that the peptidoglycan from W83 is more efficiently
hydrolyzed than in FLL92. It is likely, that the vimA dependent modification of the
peptidoglycan may contribute to a structural modification, which may lead to its relative
resistance to lysostaphin. In bacteria, o-acetylation of the peptidoglycan can modulate
turnover by reducing the activity of autolysins and endogenous enzymes (7,23,34). The
levels of o-acetylation in P. gingivalis FLL92 and W83 are unclear and the subject of
further investigation.
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In a previous report (33), we established that the VimA affects several surface
related structures including fimbriae, capsule and some outer membrane proteins. To
clarify whether this alteration in the protein profile was unique to the outer membrane or
affected all secreted proteins, mass spectrometry was performed on the extracellular
fraction. Sixty-eight proteins were identified as being aberrantly expressed in FLL92 (i.e.
missing from the extracellular fraction of W83), this was markedly more than that
observed in the outer membrane fraction (n=20). Interestingly, PG1496 - a conserved
hypothetical protein predicted to be involved in transport, is aberrantly expressed in the
outer membrane and extracellular fraction. Two other proteins with protein transport and
binding functions – PG1497 and PG1504, were also aberrantly expressed. It is likely that
these three proteins are part of a novel transporter/cell sorting system in P. gingivalis,
which when disrupted, results in alterations in secretion and anchorage of proteins. Of
note is the fact that several cytoplasmic proteins were found in the extracellular fraction
of FLL92, including those involved in energy metabolism, translation and DNA
metabolism. Though we cannot definitively rule out the possibility of cytoplasmic
contamination, the fact that these protein fractions were all prepared under the same
conditions using the same techniques, coupled with the fact that they are absent from
the wild-type fraction, which showed no contamination with the periplasmic marker used
– PG0535 (HtrA), leads us to believe that these proteins are incorrectly targeted for
secretion in FLL92. PG1857 – Glyceraldehyde 3 phosphate dehydrogenase, which is
involved in the colonization of P. gingivalis (30), is the only protein that was found to be
missing from both the membrane and extracellular fractions of FLL92. An examination of
proteins with varying spectral count values, suggest that Kgp is 6 times as abundant in
W83 compared with FLL92, while RgpA has a negative fold change of 1.2. In a previous
report, we have demonstrated that the gingipains though transcriptionally unaltered, are
translationally affected by the vimA mutation, exemplified by the secretion of the inactive
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precursor forms of these proteases (39,40). These results demonstrate that the
disruption of the VimA – gingipain maturation pathway does not only lead to different
forms being secreted, but also affects the concentration of these products. This
phenomenon was also evident for the TonB dependent OM protein (PG0170),
Carboxypeptidase D (PG0212), Hemmaglutinin (PG1602) and the Peptidylarginine
deiminase (PG1249)
Several secreted proteins have been found to have primary and secondary
structure similarity to the C-terminal domain of RgpB. These proteins have been
designated the CTD family; and members of this family are attached to the cell surface
through cell envelope glycans, which are important for proper folding and processing in
order to produce a fully functional enzyme (37). In silico analysis was used to examine
the C terminal of the missing extracellular proteins identified by mass spectrometry. We
hypothesized that there would likely be a common motif unique to all these proteins;
however, no common motif was present in missing proteins from the extracellular
fraction, suggesting that a unique C terminal motif does not account for the alterations
observed with the extracellular missing proteins.
Taken together, our results demonstrate that the VimA of P. gingivalis is needed
for the correct secretion of several extracellular proteins and is likely involved in
peptidoglycan biogenesis. This latter finding is the focus of ongoing research in our
laboratory.
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CHAPTER FOUR
DISCUSSION
P. gingivalis has several surface components that contribute to its virulence;
these include - fimbriae, major outer membrane proteins, hemagglutinin, lipid
polysaccharides, capsule and gingipains (5,24). Several genes - vimA, vimE, vimF,
porR, rfa and ugdA (10,11,15,16,19-21) have been reported by our lab and others to be
implicated in the formation of extracellular polysaccharides as well as glycan addition of
gingipain-adhesin complexes (12). It nevertheless remains uncertain, whether the
phenotypic change produced by mutations of these genes is due to the interruption of a
central pathway, or multiple pathways.
The VimA which encodes a 32-kDa protein, was the first gene identified in our
lab that showed the ability to modulate proteolytic activity. The phenotype of the vimA
mutant strain (FLL92) when compared with the wild-type parent strain W83, was: nonblack pigmented, non-virulent, had reduced hemagglutinating, hemolytic and proteolytic
activity, showed increased autoaggregation and had a truncated LPS (10,21). The
protein profile of FLL92 was also markedly different when compared to W83. Taken
together, these results suggest that VimA plays a central role in the regulation and
biogenesis of several surface structures and proteins. In this report, we address
particular gaps in our understanding (Fig. 4.1.), regarding the role of VimA in capsular
and fimbrial biogenesis, protein sorting and anchorage, acylation and glycosylation of
outer membrane proteins, as well as its likely role in peptidoglycan biogenesis.
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The VimA was predicted by in silico analysis to be closely related to the FemABX
family of proteins. These proteins are found primarily in Gram positive bacteria and are
involved in peptidoglycan biosynthesis (1,6,18). An examination of the phylogeny
suggested that VimA (0.52) is closest in relation to the FemX (0.45). Notably, the FemX
differs from the FemA and FemB which preferentially transfers amino acids to
membrane bound peptidoglycan precursors, in that it catalyzes the transfer of L-Ala onto
the cytoplasmic UDP-N-acetylmuramyl-peptapetide (UDP-MurNAc-pentapetide) (8,13).
This process involves the sequential binding of Ala-tRNA and the UDP-MurNAcpentapeptide. The ability of VimA to bind PG1101 (22), an Alanyl tRNA synthetase,
further supports this function. Several attempts have been made to localize the VimA
protein, using antibodies raised against the over expressed E. coli protein, this strategy
has thus far proven unsuccessful, however there is evidence (unpublished) to indicate
that this protein is likely cytoplasmic or periplasmic.
The role of VimA in peptidoglycan biogenesis was examined using TEM, AFM
and hydrolytic enzyme assays. The peptidoglycan sacculi from FLL92 was distinctly
different from that of W83, and had a granular appearance with numerous fine
structures; additionally, peptidoglycan from FLL92 was hydrolyzed at a slower rate than
W83. Taken together, our findings indicate a role for VimA in peptidoglycan biogenesis.
Functional assays to demonstrate the ability of VimA to transfer Alanyl from a tRNA
synthetase to the peptidoglycan are presently being pursued, as are experiments aimed
at determining the difference in the peptide component of the peptidoglycan in FLL92
compared to W83.
Two separate superfamily prediction software yielded two likely classifications for
the VimA. VimA was predicted to belong to the DUF482/CH1444 and/or the Acyl CoA Nacyltransferase superfamily. The DUF482/CH1444 family is part of the PEP-CTERM

131

system that has sortase like function (4) – involved in proteins sorting, while the Acyl
CoA N-acyltransferase superfamily is a broad family which includes the FemABX
nonribosomal peptidyltransferases family. The VimA was also predicted to interact with
several proteins including RgpB, which is consistent with previous reports demonstrating
the ability of VimA to interact with the gingipains (22).
Several reports have suggested that a correlation exists between fimbrial and
capsular synthesis and the autoaggregation phenotype observed in P. gingivalis (3).
This led us to hypothesize that the vimA mutation could effect capsular and fimbrial
biogenesis. Transmission Electron Microscopy and Atomic Force Microscopy revealed
that the capsule of FLL92 was irregular and fuzzy compared to the solid well defined
capsule of the wild-type; additionally, FLL92 had a corrugated topography compared to
with the smooth morphology present in W83. There was also increased fimbrial
detection via immunogold staining and immunoblotting. Since the transcription level of
fimA was unchanged in the mutant compared to the wild-type, hypothesize that the
expression of capsular polysaccharides may impede the phenotypic expression of
fimbriae, in a manner similar to that demonstrated in Klebsiella pneumoniae (7,14), i.e.
direct physical interaction might impede the polymerization of fimbriae on the cell surface
(Fig. 4.2.). These findings are in contradiction to a recent report which suggests, that the
inability of W83 to produce fimbriae is due to a mutated FimSR histidine kinase and the
inability of W83 FimA to polymerize on the outer membrane of the cell (9). Our findings
suggest that an alternate FimSR independent pathway may exist for fimbrial maturation.
Further studies are needed to determine whether the VimA plays a direct role in the
synthesis and regulation of these two macro-structures, and the degree of FimA
polymerization in the mutant.
Mass spectrometry was performed on proteins from the membrane and
extracellular fractions of FLL92, in order to determine the types of proteins that were
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being affected by the VimA mutation, and to elucidate whether the VimA could have
sortase-like function. In the membrane fraction of FLL92, twenty proteins were identified
as aberrantly anchored to the cell wall of FLL92, while nine proteins were missing.
Twenty proteins had variable spectral count values (normalized spectral count values
correspond to the relative abundance of the protein). In the extracellular fraction, sixty
eight proteins were identified as aberrantly expressed, while fifteen proteins were
missing and 20 had variable spectral count values.
The absence of Carboxypeptidase D on the outer membrane of FLL92 likely
explains why Kgp and RgpA are not anchored to the outer membrane, as these
enzymes require C terminal processing (2,23). Interestingly, this enzyme is present at
lower abundance in the extracellular fraction of FLL92 Compared with W83 - negative
fold change of 28. Several transport proteins and several structural membrane proteins
are aberrantly expressed or missing in this mutant. It is likely, that the absence of these
transport and structural proteins result in a disruption in the normal cell sorting and
secretion machinery, resulting in incorrect and unregulated protein secretion. Mass
spectrometry also confirmed our previous finding (21,22) that RgpA and Kgp are only
found in the extracellular fraction of FLL92; notably however, these gingipains are at
much lower levels of abundance. RgpA showed a negative fold change of 1.2, while Kgp
had a negative fold change of 6.6. Taken together, these findings support a role for
VimA in anchorage and maturation of outer membrane proteins and the correct targeting
of secreted proteins. The interaction between VimA and the missing or aberrantly
expressed outer membrane and extracellular proteins, is an active area of investigation.
Previous reports in our lab have highlighted the aberrant protein glycosylation
that occurs in FLL92 (21); however, not much is known about the particular carbohydrate
moieties involved in this aberrant glycosylation profile. Lectin binding assays allowed for
the identification of these moieties. Outer membrane proteins glycosylated with
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Galactose (β 1,3) N-Acetylgalactosamine, N-acetyl-α-D-galactosamine, Galactose (β
1,4) N-Acetylglucosamine, N-acetyl-D-galactosamine and Sialic Acid (N-Acetyl neuramic
acid) were affected by the vimA mutation. These findings indicate a role for VimA in the
correct glycosylation of membrane proteins.
Lipid modification of outer-membrane proteins in P. gingivalis has been well
characterized (17), based on the characterization of VimA (A putative acyl transferase),
we hypothesized that it would play a role in the acylation of one or more membrane
proteins. Using 3H labeled palmitic acid as the lipid donor, the role of VimA was
examined. No changes were observed in the lipid modified protein profile of the wild-type
total protein fraction. Comparatively, distinct differences were observed in the
extracellular fraction of FLL92 when compared with W83. A 54 kDa protein was three
times more abundant in W83 than in FLL92, while a 27 kDA protein was twice as
abundant in FLL92 compared with W83. These results suggest that the VimA is
important for the correct acylation of a 54 kDa protein in the extracellular fraction, or that
acylation may be required for dimerization of the 27 kDa protein. Several studies are
presently ongoing with a view to clarify this observation.
Our findings support the view that VimA is a multifunctional – multi domain
protein, involved in the regulation of membrane components including – fimbriae,
capsule, and peptidoglycan. This protein is also involved in the sorting and secretion of
several proteins and plays a role in the correct glycosylation of several outer membrane
proteins and the correct acylation of at least two secreted proteins. Our results indicate a
putative central role for the VimA protein in membrane biogenesis, protein modification
and transport. These putative multiple functions require further elucidation.
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